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ABSTRACT

This dissertation focuses on three key facets of health IT impact on the practice of medicine: (1)
Clinical impact on practitioner outcomes through malpractice claims, (2) Socio-economic impact on patient
outcomes through the clinical treatment of social determinants of health (SDOH), and (3) Organizational
impact on Long-Term Post-Acute Care (LTPAC) Facilities. The first dissertation essay (Chapter 1)
investigates the impact of Health IT on the nature and severity of malpractice claims reported in Florida
from 2009-2016. The essay empirically examines the treatment effect of federal initiatives, specifically the
Meaningful Use program, on medical practitioners enrolled in the Medicare program and actively practicing
medicine in Florida during 2009-2016. It further investigates the observed treatment effect in terms of
information failures captured in malpractice claim case details using machine learning algorithms. This
work provides empirical evidence towards the beneficial impact of Health IT on the provider-outcomes
with implications towards policy and operations. The second dissertation essay (Chapter 2) examines
whether SDOH factors affect the quality of care a patient receives during initial treatment and whether these
variations in quality significantly impact readmission likelihood. The essay demonstrates that even though
physicians account for socioeconomic factors when making treatment decisions, these adjustments do not
impact long-term health care outcomes. However, SDOH factors still impact long-term patient outcomes
in terms of readmission likelihood. The third essay (Chapter 3) examines how and to what extent Health IT
and electronic health record (EHR) adoption affect organizational capability configurations of long-term
and post-acute care facilities (LTPAC) for high performance in terms of measurable outcomes. The essay
provides a configurational perspective accompanied by a fuzzy-set qualitative comparative analysis
(fsQCA) to explain complex nonlinear relationships among key digital and non-digital capabilities
influencing facility-level measurable outcomes for 18 months [Jan 2016 – Jun 2017]. This shifts attention
v

from individual capabilities to configurations of capabilities to develop a better understanding of the
complex role of Health IT in the practice of medicine at the organizational level.
In recent years, the United States healthcare system has been overwhelmed with a technological
makeover. Although technology can be attributed to many benefits, assimilation, and use of technology
have been synonymous with a double-edged sword. Technology impacts the various stakeholders in the
healthcare system as well as public policy. This dissertation proposes to estimate the differential impacts
of technology on socio-economic aspects of healthcare delivery, the practice of clinical medicine, and the
management of healthcare organizations. Although healthcare technology seems to be a concise term, it’s
an amalgamation of components like pharmaceuticals, medical equipment, medical procedures, and health
information technology (HIT). In this research project, we particularly focus on the HIT component and its
impact and influence on healthcare outcomes.
The first essay investigates the impact of Health IT on the nature and severity of malpractice claims
reported against non-hospital-based medical practitioners in Florida from 2009-2016. As the healthcare
costs in the US rise at an alarming rate, medical liability claims significantly contribute to it. In addition to
economic losses, medical malpractice compromises patient safety and provider reputation. Several federal
and state initiatives like Meaningful Use work towards Health IT adoption and use. Our study empirically
examines the treatment effect of these state initiatives, specifically the Meaningful Use program, on
malpractice risks of the medical practitioners, enrolled in the Medicare program, actively practicing
medicine in Florida during 2009-2016. It further investigates the observed treatment effect in terms of
information failures captured in malpractice claim case details using machine learning algorithms. The
results provide empirical evidence towards the positive role of Health IT on medical practitioners by
lowering their risk to malpractice claims. Additionally, an exploratory text analysis of malpractice claims
records helps uncover the latent mechanism through which the treatment effect of Health IT shows up in
malpractice claims likelihood. We find the practitioners with a higher demonstrated ability of Health IT use
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in their practice are associated with a reduction in practitioner-based errors in the malpractice claims
reported against them. This work has enormous implications for both practice and policy.
The second essay empirically investigates the physician decision-making process and its impact on
patient readmission likelihood at a large, academic, urban hospital. Increased complexity of situations
encountered by the physicians during their day-to-day practice necessitates technological support from
physician decision support systems. These systems focus on clinical condition-based decisions and ignore
the impact of patient behaviors on the clinical processes, or provider issues, such as malpractice. The goal
of this work is to understand how physicians alter their decision-making process for different patient types
during chronic care treatments, and whether these adaptions are purely clinical, or if they include other
factors such as socio-economic status, and if so, when should they account for both. This study has
important implications for the design and use of decision support systems as part of Health IT systems
integrated within the medical practices. The decision support systems are based on clinical markers and
provide warnings and suggestions to aid physician’s clinical decision-making process. Some recent debates
argue about making these systems sensitive to social and economical attributes and markers of patients to
provide holistic healthcare. This study analyses the impact of socio-economic factors perceived by the
physician on his/her decision making and then the final impact of this decision’s long-term impact on the
healthcare outcomes of the patient in the form of readmission risk. We found although socio-economic
factors perceived by the physician during the clinical encounter results in significantly different clinical
decisions ceteris paribus, the effect of this difference did not significantly affect the readmission risk of the
patient. These findings have important implications for medical education and the design of decision
support systems. The paper establishes the clinical treatment of social diagnosis is not useful and needs
proper address through policy, education, and designs of decision support systems.
The third essay examines how and to what extent Health IT and electronic health record (EHR)
adoption, as well as use, affect organizational capability configurations of long term and post-acute care
facilities (LTPAC) for high performance in terms of measurable outcomes. The study adopts a
vii

configurational perspective accompanied by a fuzzy-set qualitative comparative analysis (fsQCA) to
explain complex nonlinear relationships among key digital and non-digital capabilities influencing facilitylevel measurable outcomes for 18 months [Jan 2016 – Jun 2017]. This work shifts attention from individual
capabilities to configurations of capabilities to develop a better understanding of the complex role of Health
IT in the practice of medicine at the organizational level. We find Health IT is necessary but not sufficient
condition for the high performance of an LTPAC facility. We find a significant impact of Health IT in
clinical and operational performance but not financial performance. Our results indicate the absorption of
Health IT impact within financial performance takes longer compared to operational and clinical
performance.
This dissertation provides empirical and qualitative evidence of the impact of health IT on various
aspects of medical practice. Health IT not only reduces the medical practitioners’ malpractice claim risks
but also improves the operational and clinical performance of LTPAC facilities over a short period. We
ascertain financial benefits to accrue at a later stage for these facilities. Health IT has been instrumental in
emphasizing the role of socioeconomic factors in clinical decisions and the long-term outcomes of patients.
We find using Health IT tools efficiently to avoid clinical treatment of social diagnosis potentially saves
medical resources and appropriates correct treatment through social interventions and policy.

viii

CHAPTER ONE:
PRESCRIPTION TO MEDICAL PRACTITIONERS: MEANINGFUL USE OF HEALTH-IT
FOR MALPRACTICE RISKS
1.1

Abstract
Medical liability or malpractice claims not only lead to defensive medicine resulting in ever-

increasing healthcare costs but also raise concerns about patient safety and the reputation of medical
practitioners. While prior research suggests that Health IT (HIT) adoption improves the quality of care,
evidence about its impact on medical errors or malpractice claims has been mostly inconclusive. Moreover,
there is a lack of evidence of direct tangible benefits to medical practitioners due to the adoption of HIT.
We use a unique dataset of more than 25,000 medical practitioners for the period 2009-2016 to investigate
the impact of the meaningful use of HIT as defined by the Center for Medicare and Medicaid Services
(CMS) on reported malpractice claims. We find that the relative risk of malpractice claims declined by
around 65% with successful attestation to CMS MU-Stage-1, which is based on demonstrated electronic
data capture and sharing. The risk further declines by around 35% with subsequent attestation to CMS MUStage-2, which certifies the use of IT in advanced clinical processes. To unbundle the mechanisms through
which the impact of HIT on malpractice claims is realized, we perform a thematic content analysis of
malpractice claim records using the topic-modeling approach and provide evidence for the decline of
practitioner-based medical errors after the meaningful use of Health IT. Our research is one of the first to
provide evidence of a link between effective use of HIT and direct benefit to medical practitioners, through
a decrease in risk of malpractice claims due to reduced practitioner-based medical errors.

1

1.2

Introduction
Burgeoning national healthcare costs in the US, estimated to rise to 19.9% of GDP by 2025, have

been a major concern for the healthcare industry as well as for policymakers (Fedor and Zhang 2020;
Holpuch 2020; Saad 2019; Sahadi 2018). There is strong evidence that the medical liability system, which
largely consists of malpractice claims against the medical practitioners, is a significant contributor to these
costs because high medical liability costs give rise to a culture of defensive medicine and overtreatment
(Baicker et al. 2007; Kessler 2011; Mello et al. 2010; Raposo 2019). Malpractice claims arise due to actual
or perceived medical errors, which in turn lead to poor quality of healthcare services, and this poor quality
eventually hurts patients (Andel et al. 2012; Institute of Medicine 1999). While medical errors negatively
impact patients in terms of adverse health outcomes, medical practitioners also suffer substantial financial
costs in terms of malpractice claims and malpractice insurance premiums (Menon and Kohli 2013;
Ransbotham et al. 2011; Ransbotham and Overby 2010; Studdert et al. 2005) and reputation loss
(Reschovsky and Saiontz-Martinez 2018). Prior research has shown that, in the absence of technological
support systems, the malpractice laws by themselves are inadequate in reducing medical errors to improve
healthcare quality (Minami et al. 2017).
With substantial advances in Health Information Technology (Health IT), there has been significant
interest in the IS domain to understand the mechanisms through which adoption of Health IT may lead to
better patient outcomes and create value for hospitals (Hydari et al. 2019; Lin et al. 2019; Ransbotham et
al. 2020; Sharma et al. 2019; Wani and Malhotra 2018). While adoption of Health IT and increased use of
Electronic Health Records (EHRs) may lead to reduced malpractice risk and improvements in quality of
care (Meeks et al. 2014; Menon et al. 2000), it may also lead to an increased malpractice risk with intricately
detailed electronic paper trails offering discoverable legal evidence with lower legal resolution time
(Hoffman 2010; McGraw et al. 2013; Paterick et al. 2018; Ransbotham et al. 2020). Furthermore, medical
practitioners have either been largely indifferent to or have resisted the use of IT in medical practice because
of a lack of evidence of any direct value creation for them while the direct costs in terms of up-front financial
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investments in IT infrastructure and expertise, disruption in clinical workflow, increased perceived risk of
a malpractice claim, and reduced quality time with patients, have been very apparent (Boonstra and
Broekhuis 2010; Miller and Tucker 2014; Sittig and Singh 2011).
Prior research offers limited insights into the effect of Health IT on malpractice claims as the
researchers have overwhelmingly focused on hospitals and IT adoption only (Ransbotham et al. 2020;
Sharma et al. 2019). The persistent argument of whether meaningful use of Health IT reduces the risk of
malpractice claims by improving information processing and reducing the occurrences of medical errors
(Aron et al. 2011; Hydari et al. 2019; Meeks et al. 2014), or whether medical errors are not enough to
compensate for the increased likelihood of leaving an evidence-trail in case a medical error occurs, that
increases the overall risk of malpractice claims. The overall impact of meaningful use of Health IT on the
risk of a malpractice claim is an outcome of a complex interaction of these two plausible pathways, leaving
the question of Health IT impact still open.
In recent years, despite drastic improvements in Health IT adoption rates, the healthcare industry
continues to struggle with motivating medical practitioners to make extensive use of Health IT in their
clinical practice (Ford et al. 2009). Keeping in view the challenges in the adoption of Health IT, federal
initiatives like the Meaningful-Use (MU) incentive program were introduced by the Centers for
Medicare/Medicaid Services (CMS) and the Office of the National Coordinator for Health IT (ONC) to
overcome barriers to adoption and to promote adoption and meaningful use of Health IT. While these
initiatives provide incentives towards meaningful use of Health IT, they have not been met with
overwhelming enthusiasm by medical practitioners (Ajami and Bagheri-Tadi 2013). This raises the
intriguing question of whether meaningful use of Health IT benefits medical practitioners in ways not
realized before. If so, then how? What are the mechanisms underlying any such beneficial effect?
Healthcare is an information-intensive industry pivoting on the criticality and the time-sensitivity of
information (Von Lubitz and Wickramasinghe 2006). Medical practitioners routinely process multiple
information cues at any given time. Contingent upon efficient and meaningful use, technology offers
3

improved patient data recording, authorized anytime-anywhere shared record access, efficient
communication features, safety alerts, reporting capabilities, remote-connectivity, automated medication
safeguards, and real-time clinical data collection, integration, and analysis. We posit that one of the key
aspects of clinical practice that is impacted by the meaningful use of Health IT is the likelihood of medical
error on the part of the practitioner; reduction of practitioner errors would likely lower malpractice claims
against the practitioner. Additionally, malpractice claim record details hold insights into the mechanisms
through which Health IT influences medical errors as part of these claims.
In other words, we posit that Health IT reduces the likelihood of a medical error and thereby
indirectly impacts the medical practitioner’s potential costs due to malpractice claims. This motivates us to
investigate the following two research questions: (1) How does the demonstrated Health IT capability of
medical practitioners impact the risk of malpractice claims reported against them? and (2) What are the
pathways through which the use of Health IT impacts the risk of malpractice claims, specifically on the
medical errors alleged in the reported claims?
Prior research on the impact of Health IT on health outcomes is still inconclusive (Atasoy et al. 2019;
Barnett et al. 2016; Black et al. 2011; Yanamadala et al. 2016). While some researchers report positive
Health IT impact leading to improved health outcomes (Bhargava and Mishra 2014; Hah and Bharadwaj
2012; Hersh et al. 2014; Hydari et al. 2019), others find some of these studies unconvincing due to limited
sample size or weak methodology (Aron et al. 2011; Sodero et al. 2013). Prior research has also highlighted
limitations caused by inaccurate measurement of the value of Health IT (Barnett et al. 2016),
representativeness of the sample restricted to often one hospital or to non-random selection of patients
(Aron et al. 2011), and lack of generalizability of results (Appari et al. 2013; Atasoy et al. 2019).
Within the broad domain of the impact of Health IT on health outcomes, a sub-stream has studied
the impact of Health IT on patient safety and the risk of malpractice claims. A recent study in Pennsylvania
hospitals examines the impact of advanced EHRs and the moderating effect of Health IT on patient safety
indicators (Hydari et al. 2019), while another focuses on hospitals in Washington for impact on the
4

Malpractice Insurance Premiums (MIP) as well as patient quality of care (Menon and Kohli 2013). Another
group of researchers used data from hospitals to examine the impact of Health IT on patient outcomes like
the length of stay (Wani and Malhotra 2018). A recent study reported positive effects of EHR on the quality
of care in hospitals, which was specifically significant for meaningful use compared to just adoption alone
(Lin et al. 2019). These researchers also found the effect size larger in rural and small hospitals, thereby
suggesting disparity mitigating effects of technology on hospital outcomes. Recent studies examining the
impact of the adoption of Health IT by hospitals on their malpractice claims and resolution time appear to
have significant overlap with our research but are significantly different in certain critical aspects
(Ransbotham et al. 2020; Sharma et al. 2019). While these studies marked considerable improvement over
prior methodological and data-related limitations, all of them focus on the impact of Health IT on patient
outcomes at the hospital level and not its impact on medical practitioners. Additionally, these studies focus
on Health IT or EHR adoption based on survey data, inundated by inherent survey data limitations and
biases. It is critical to understand the difference between mere adoption of EHR and certified or attested
meaningful use of Health IT. While adoption precedes meaningful use of technology, it does not
automatically imply the latter. We do acknowledge the fact that practitioners could have adopted EHRs
way before the MU program rollout. With the reward-penalty scheme of the program we believe there is
no rational objective which can lead any practitioner to not attest to MU-stage while they possess capability
to demonstrate required criteria. The program does not distinguish between the group of providers who
attest and those who do not. This allows us to consider MU-program as external exogeneous event for our
Difference-in-Difference model evaluation. MU-program attestation data provides how IT is being used in
clinical practice and is a more comprehensive indicator of Health IT usage than EHR adoption.
For this study, we constructed a unique dataset by merging relevant information from five public
data sources: the Florida Office of Insurance Regulation’s Professional Liability Claims Reporting
database; Medicare Provider Enrollment, Chain, and Ownership System (PECOS) data files; MeaningfulUse (MU) attestation data files; Florida Department of Health’s Practitioner Profile Dataset; and National
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Plan and Provider Enumeration System (NPPES) public-use data files. Our dataset is composed of 25650
Medicare Eligible Professionals who were active in Florida during our observation period of 2009-2016.
Our empirical strategy addresses non-random self-selection into attestation and the endogeneity of
unobserved professional diligence and conscientiousness, which influences both malpractice-claims
likelihood as well as MU-Stage attestation choice. We perform the Difference-in-Differences (DiD)
estimation strategy with the Linear Probability model to strengthen our investigation and results (Mood
2010; Wooldrige 2011). Additionally, we perform several robustness checks to confirm the validity of our
results. Since our dataset contains closed claims, someone might worry about the suitability of the data for
addressing the research question. As claims take around 4-5 years till final disposition since the time of
occurrence of the alleged injury. We also observed that in our dataset, the treatment group and the control
group have a comparable frequency of resolution times in days. This implies the legal process is the same
for both treatment and control groups. Therefore, we perform the same analysis by restricting data to 2014,
2015, and 2016 to find the DiD coefficient is significant and has the same values.
We examine the impact of Health IT on medical practitioners by analyzing medical malpractice
claims reported against licensed medical professionals in Florida between 2009 and 2016. When licensed
medical practitioners attested for MU-Stage-1, we found the relative risk of a malpractice claim being
reported declines by around 65%. Similarly, when licensed medical practitioners attested for MU-Stage-2,
we found the relative risk of a malpractice claim being reported reduced by around 35%. In both cases, the
likelihood of malpractice claims, and the probability of medical errors is reduced with an increase in
demonstrated Health IT capability measured through meaningful use attestation. Our study provides
evidence that Health IT capability directly benefits medical practitioners by lowering the likelihood of a
malpractice claim through indirect mechanisms.
A clear understanding of these indirect mechanisms would help in uncovering the pathways through
which Health IT impacts patient outcomes. Therefore, we investigate the thematic content of a corpus of
malpractice claims of pre- and post-MU-Stage certified medical practitioners. Through analysis of a large
6

corpus of medical malpractice claim records using human evaluation coupled with the topic modeling
approach, we find the practitioner-based errors declined with increased meaningful use of certified EHR
technology. These results help trace the pathway leading Health IT to a reduction in malpractice claims
through a drop in latent practitioner-based errors. Our contextual framework provides a deeper
understanding of how the benefits from Heath IT are realized.
Our study is special in two key aspects. First, we use a large data set at the level of individual medical
practitioners in the state of Florida, and therefore, our research focuses on the impact of Health IT
physicians who are a critical link in healthcare delivery. Second, we directly take into consideration the
impact of Health IT on medical errors, and this analysis has direct consequences for the physicians.
Therefore, we bridge the gap in the existing literature by investigating business value creation by Health IT
for medical practitioners. Furthermore, we employ a topic modeling methodology from computational
linguistic research to extract thematic content from malpractice claim reports to further examine
mechanisms through which Health IT affects medical errors and malpractice claims. Thematic content
modeling of malpractice claims enables us to observe the links among patient safety, quality of medical
service, and meaningful use of Health IT. We extend the methodology used by (Huang et al. 2014) to
Information Sciences (IS) in the healthcare management domain by utilizing improved methods to analyze
case details and medical records through unsupervised machine learning.
We examine the effective use and assimilation effect of Health IT, advancing the academic debate
regarding the efficacy of Health IT from adoption to its meaningful use. Researchers have considered
several weak proxies of Health IT adoption and use such as IT investments, available EHR components,
and surveys. However, these proxy variables do not adequately measure “meaningful use of IT”. Our study
belongs to the group of a few recent ones that have used MU program regulations as a proxy for Health IT
use (Lin et al. 2019; Wani and Malhotra 2018). The MU program criteria provide a standardized
measurement of Health IT usage which is less noisy than other proxies. Lin et al. (2019) and Wani and
Malhotra (2018) use the MU program as a proxy for Health IT use, but they examine hospital outcomes
7

like the length-of-stay (LOS) and patient-safety-indicators (PSI) on study sample data obtained before 2014.
In contrast, our study is the first to examine the impact of meaningful use of Health IT on malpractice
claims, specifically focused on the benefits to the medical practitioners. Moreover, our study’s observation
period of 2009-2016 is fairly recent, improving the applicability and implications of our results. Noticeably,
very little research in the IS domain has been conducted to show the impact of Health IT on medical
malpractice claims (Menon and Kohli 2013; Ransbotham et al. 2011; Ransbotham and Overby 2010). Our
study is also one of the first to examine Health IT’s impact on malpractice claims likelihood and to reveal
latent intrinsic mechanisms of this effect using the topic modeling approach coupled with human
evaluations. Our results and findings provide strong evidence-based support for the positive effects of
meaningful use of Health IT.
Furthermore, our study justifies investments in an organizational focus on IT for healthcare
organizations. This study is limited neither to any special category of the patient population nor to any
specialty of medical practitioners, overcoming most research concerns about generalizability. Additionally,
we use panel data set for years 2009-2016, allowing us to better capture the effects of the HITECH Act
compared to studies that use data before the year 2010 (Devaraj and Kohli 2003; Miller and Tucker 2011),
or only up to 2014; those studies were not able to capture the effect of MU-Stage-2 certification which
started only in the year 2014 (Hydari et al. 2019; Wani and Malhotra 2018; Yanamadala et al. 2016).
Overall, this study has important policy implications for both healthcare policy and medical practice.
1.3

Research Context and Literature Review
In this section, we first provide the research’s context by describing key features of the meaningful

use certification process of CMS and an overview of the malpractice claim process. Then we discuss the
reference literature in three sub-streams to highlight how our work is related to prior work and how we
contribute to these sub-streams within the broad domain of the impact of Health IT on the healthcare
landscape.
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1.3.1

Research Context
Health IT is an all-inclusive term for information and communication technologies used by medical

practitioners to support health information management. Although many IT applications play a role in
improving the overall quality of healthcare delivery and patient safety, EHRs play a prominent role. For
this reason, we use the terms Health IT and EHR interchangeably for technology used in the healthcare
domain. Health IT applications include clinical data repository (CDR), clinical decision support system
(CDSS), computerized practitioner order entry (CPOE), physician documentation (PD), order entry (OE),
business intelligence–clinical, patient portal, and physician portal (Atasoy et al. 2019; Hydari et al. 2019).
Other systems integrated with the EHR system include Laboratory Information System (LIS), Radiology
Information System (RIS), Pharmacy Information System (PIS), Health Information Exchange (HIE)
systems, and Registration, admissions, discharge, and transfer (RADT) systems.
1.3.1.1

Definition of Meaningful-Use1
Empowered by the HITECH Act, CMS grants an incentive payment to Eligible Professionals (EPs)

or Eligible Hospitals (EHs), who can attest that they have engaged in efforts to adopt, implement or upgrade
certified EHR technology (CEHRT). The Meaningful-Use (MU) program was rolled out in a phased manner
in three stages: 2011 (data capture and sharing), 2014 (advanced clinical processes), and 2018 (improved
outcomes). Since there are inherent challenges in collecting practitioner-level Health IT use data, largescale inferential studies on the Health IT impact, like ours, are extremely rare. We capitalize on the MU
program provisions of the HITECH Act to quantify different levels of Health IT use by a heterogeneous set
of medical practitioners licensed in Florida and enrolled in the Medicare program. The MU regulation
protocols naturally distinguish between different levels of Health IT use through specific objectives in the
three stages. Each MU-Stage builds on the previous stage in a way that Health IT use at that stage is more
relevant and comprehensive than the previous one. The primary goal of the MU program and these

1

In this subsection we summarize relevant information for our context from the CMS website:
https://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms
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legislative rules is to extend the effective use of Health IT beyond mere adoption, to achieve significant
improvement in care.
The MU program provides us with an objective, formal, and context-specific metric of practitionerlevel Health IT use. When practitioners attest to a higher MU-Stage, it means they are using EHR
applications more intensively and using more advanced applications within their EHRs. MU-Stage-1
requires practitioners to complete 15 core objectives, 5 out of 10 menu objectives, and 6 total clinical quality
measures. Meanwhile, MU-Stage-2 requires them to demonstrate 17 core objectives and 3 out of 6 menu
objectives. Each of these objectives is accompanied by a specific measurable EHR use requirement.
Participation in the MU program is voluntary; however, practitioners failing to join by 2015 faced
reductions to their Medicare/Medicaid payments, starting at a 1% reduction and escalating to a maximum
of 5% annual adjustment. Post attestation, EPs are also required to continually maintain and report their
status in subsequent years for recurring payments. Consequently, this reward and penalty scheme promotes
intensive and advanced use of EHRs at the point of care, encouraging practitioners to attain the MU criteria
sooner rather than later. With no opt-out option and most medical practitioners in the United States subject
to the MU regulation, large-scale inferences in our study become a possibility.
1.3.1.2

Medical Malpractice Claims Process2
A medical malpractice claim originates when the patient believes the quality of care provided was

compromised, either by a diagnosable, avoidable, and/or preventable medical error, or medical negligence
(Moore et al. 2000). There is evidence to suggest that 1 in 7 adverse events in medicine result in a
malpractice claim mostly due to distrust originating from a prior poor patient-practitioner relationship
(Oyebode 2013). Although a malpractice claim can be filed due to relationship distrust, it requires clinical
evidence to survive the discovery process and later litigation process.

2

In this section we summarize information from the following legal sources:
https://www.floridabar.org/the-florida-bar-journal/florida-medical-malpractice-and-the-statute-of-limitations
http://www.leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0700-0799/0766/0766.html
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Medical facilities and insurance carriers thoroughly evaluate risks associated with each malpractice claim
before it moves to trial. A settlement is a favorable option compared to a trial since it allows the client and
the law firm to intelligently participate in a non-binding negotiation process. Sometimes the negotiations
are handled between counsel, but often mediation is utilized. During these negotiations, if both parties agree
on a dollar amount that fully and fairly compensates the plaintiff for their injuries, and the plaintiff agrees
to accept that sum, then the settlement successfully concludes the case. If the settlement process fails with
direct negotiations, then mediation or arbitration takes place, and, in the end, a trial takes place. The results
of a trial are neither certain nor guaranteed. With the involvement of medical facilities and insurance
carriers, a settlement is the most common outcome. Most cases settle after meeting the Medical Malpractice
Tribunal requirement for proceeding to trial.
The dynamics of the settlement process critically depend upon the insurer’s assessment of the
standard of care (Peeples et al. 2002; Peters 2009). Our study focuses on the malpractice claim reports,
instead of settlements and final dispositions, because of the inherent complexity of the legal process. Also,
we analyze the medical adverse event specified in the claim report based on the date of its occurrence to
close the legal and procedural time gap between the event and its reporting.
1.3.2

Literature Review
In the early 2000s, when Health IT was a new technology full of potential, several studies were

focused on Health IT adoption and its value creation (Agarwal et al. 2010; Devaraj and Kohli 2003). With
increased adoption, literature started to focus on the efficient use and business value of Health IT (Jones et
al. 2014; Wani and Malhotra 2018). Per se, it is highly likely that effective meaningful use, rather than the
mere adoption of the technology or its acquisition, is the real source of Health IT's impact on healthcare
outcomes. From this perspective, our work relates to literature in three sub-streams: the impact of Health
IT on patient outcomes; the impact of Health IT on medical practitioner outcomes and malpractice claims;
and the use of topic modeling in the Health IT domain and its interpretability.
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1.3.2.1

Health IT Impact on Quality of Care and Patient Outcomes
The extant literature provides inconclusive evidence of the impact of Health IT on healthcare

outcomes and quality of care, and most studies analyze hospital-level patient outcomes (Atasoy et al. 2019;
Black et al. 2011). There is no consensus on the direction of Health IT impacts on healthcare outcomes,
with some studies finding a significant positive effect (Adler-Milstein et al. 2015; Appari et al. 2013;
Bhargava and Mishra 2014; Miller and Tucker 2011), with others reporting either insignificant effects
(Agha 2014; Appari et al. 2012) or mixed-effects (Jones et al. 2010; McCullough et al. 2010). Some of the
prior studies also have limitations including small sample size, weak methodology, inaccurate
measurements, and narrow scope of Health IT adoption (Barnett et al. 2016). Other studies observe patient
sub-populations and single hospitals losing adequate representation and generalizability (Appari et al. 2013;
Atasoy et al. 2019).
Although recent studies have improved on the methodology and shifted focus to effective use of
Health IT from that of mere adoption, they provide insights into the impact of Health IT on hospital-level
patient outcomes and quality of care and do not examine practitioner-based outcomes (Hydari et al. 2019;
Lin et al. 2019; Wani and Malhotra 2018). Our study bridges these critical gaps in analysis. We study
malpractice claims which are directly related to both patient safety outcomes and practitioner-based
outcomes. Our data spans 2009-2016, covering both MU-Stage certifications.
1.3.2.2

Health IT Impact on Practitioner Outcomes and Malpractice Claims
Extant research has studied the impact of Health IT on the risk associated with malpractice

insurance premiums (Menon & Kohli, 2013), and has established an association between Health IT and
decreases in medical errors caused by inappropriate clinical practices and ineffective therapies (Akenroye
et al., 2014). While previous research on the economics of medical errors and adverse drug events has
primarily focused on hospital performance and patient health outcomes (David et al., 2013), our approach
draws upon the likelihood of malpractice claims to assess the frequency and nature of medical errors that
prompt them.
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While some researchers have shown reduced malpractice risk coupled with improvements in quality of care
with the increased use of EHRs (Meeks et al. 2014; Menon et al. 2000), others have suggested increased
malpractice risk with intricately detailed electronic paper trails offering discoverable legal evidence
(Hoffman 2010; McGraw et al. 2013; Paterick et al. 2018). Additionally, physician resistance, up-front
financial investments, lack of technical expertise, clinical workflow disruption, and reduced quality time
with patients, were reported as some common factors leading to the adverse impact of Health IT on health
outcomes in the early 2000s (Boonstra and Broekhuis 2010). Moreover, the medical practitioners face a
legal, ethical, and financial dilemma (Sittig and Singh 2011), leading to their resistance towards adoption
and use of Health IT (Miller and Tucker 2014). There is no clarity regarding the effect of Health IT on the
malpractice claims mainly because of two opposing reasons. Firstly, Health IT improves clinical outcomes
and processes, leading to an improvement in medical practitioners’ performance and a reduction in medical
errors. The other reason is that a Health IT interface can interfere with the clinical decision-making process
and increase the likelihood of medical errors (Vartak et al., 2009). In our study, we investigate the problem
in-depth to clearly understand the Health IT effect on malpractice claims and medical errors, enabled by
our unique dataset.
We focus on practitioner-based outcomes to provide evidence that the adoption of Health IT has
the potential to directly benefit medical practitioners, which in turn may reduce their resistance to adoption
of Health IT. Moreover, the recency of the data in our study provides current relevance in the dynamically
evolving healthcare industry.
1.3.2.3

Topic Models and Human Interpretability
Several technologies that improve navigation and assimilation of text corpora use topic modeling

algorithmic approaches like the Latent Dirichlet Allocation (LDA) (Blei et al. 2003). The topic modeling
approach provides low-dimensional document representations and helps compute the similarity between
documents. LDA has previously been used to reduce dimensionality to themes for representing a summary
of contents within a large collection of documents, statically or over time (Hall et al. 2008; Liu et al. 2012).
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The LDA algorithm can increase navigability in large text collections, without the aid of human
validation, by connecting documents that have similar mixtures of topics (Griffiths et al. 2004; Steyvers
and Griffiths 2006). LDA topics have been performed inferentially closer to human interpretability and
matching in most of the exploratory analyses (Dinakar et al. 2012). Incorporating human knowledge in
unsupervised learning is a promising approach to creating high-quality topic models and researchers have
proposed a variety of human-in-the-loop methods for users to directly manipulate and incrementally refine
a topic model and its interpretability (Lee et al. 2017). Along the same lines, some researchers have used
individuals with expert knowledge to explore the human understanding of the topics to improvise the
interpretability of the topic models (Chang et al. 2009; Gretarsson et al. 2012).
A large collection of claim records poses the challenges of search, comprehension, and discovery
just like other topic-model applications. In our study, we perform a thematic content analysis of malpractice
claims using a topic modeling approach (Bao and Datta 2014; Huang et al. 2018). Inspired by recent
advances in human-in-the-loop methodology in topic modeling, we use LDA matched with human
perceptions of similarity and judgment to corroborate our intended use, instead of relying on assumptions
of ﬁt. We contribute to the domain of Health IT by showing the usefulness of the topic modeling method
coupled with the human-in-the-loop approach in discovering latent pathways through which Health IT
impacts clinical practice and leads to a reduction in medical errors. Furthermore, we also provide a novel
methodology for the literature of human-in-the-loop topic-modeling approaches.
1.4

Conceptual Model and Hypotheses
Prior academic research (Hill et al. 2007; Oyebode 2013; Stevenson et al. 2013), as well as practice

literature in the medical profession (Berlinger 2008; Michon 2014), suggest that medical errors, which may
occur at the practitioner level or hospital level, are key drivers of malpractice claims. While medical errors
may be due to various reasons including treatment failure and medication errors (Michon 2014), prior
research has highlighted the important role of information availability and processing in medical errors
(Appari et al. 2012; Gawande et al. 2003). Therefore, before discussing our empirical strategy, we first
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develop a conceptual model, based on the healthcare-services delivery process, to understand the
relationship between information processing which is achieved through Health IT, and malpractice claims.
A patient’s perception of the low quality of care or quality of care below expectation leading to the
filing of a malpractice claim can be due to adverse events or unrealistic expectations given the patient’s
innate conditions and/or state of medical knowledge. A medical malpractice claim, under the law, requires
a standard-of-care violation resulting in injury with significant damage to the plaintiff (Bal 2009). When a
patient experiences an unexpected incident or outcome, he/she may decide to initiate a malpractice lawsuit.
Once filed, the lawsuit generally undergoes three phases – Pre-suit phase, Discovery phase, and Trial, of
the litigation process, and a claim may be dismissed, abandoned, or settled by parties at any time during the
litigation process. Those malpractice claims which arise from unrealistic expectations are dropped at the
initial stage itself. Figure 1 describes the general litigation process for malpractice claims.
The first phase involves notifying the defending physician, who in turn alerts his/her malpractice
insurance carrier. The defendant responds to the claim, and, based on the response, the claim is either
abandoned or settled or moves to the second phase. In the second phase, evidence discovery, documents,
and information are exchanged among parties along with testimony exchange. Alternate dispute resolution
(ADR) efforts, which include court-sponsored or private mediation, arbitration, informal negotiation, and
judicial settlement conferences, are employed by parties to resolve the dispute to avoid the expense and
time overhead of a trial. This phase provides all the stakeholders with an opportunity to better understand
the facts and issues of the case, and many cases are dropped or settled during this phase.
The final phase of the litigation process is the trial which proceeds through legal statements,
arguments, directed verdict, and judicial deliberation. The judge or jury decides liability and economic/noneconomic damages and delivers the verdict. The final disposition is recorded in a judgment document by
the lawyers in the end. This marks the end of the litigation process if no appeal request is filed by either
party.
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Figure 1.1: Legal process of disposal of medical malpractice claims
To understand the role of information processing/availability in medical error and subsequently on
malpractice claims, we explore the discovery phase at a granular level. In this phase, evidence and facts are
uncovered to determine if the malpractice claim resulted from a medical error. Figure 2 establishes the link
between a malpractice claim and a medical error, by elaborating on the discovery phase of the litigation
process. An adverse event is defined to be any untoward medical incident and may not necessarily indicate
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medical negligence. In the absence of adverse events, injury and subsequent damages cannot be established,
and the case is either dismissed or abandoned or sometimes the claim is settled for some token amount. In
the presence of an adverse event, further investigations of the adverse event are performed through a
detailed examination of medical records to determine if the patient’s innate condition was responsible for
the adverse event. Once the patient’s innate condition is ruled out as the reason for an adverse event, experts
further assess the standard of quality of care delivery to determine if the standard quality of care was
compromised; if yes, then it is determined that prima facie there is enough evidence to support the
conjecture that the adverse event was due to medical error.

Figure 1.2: Process of establishing medical errors during the discovery phase in malpractice claims
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To understand the possible impact of Health IT on medical errors, which in turn impact malpractice
claims as well as the outcomes of those litigations, we investigate a typical medical practitioner’s work
routine process consisting of both direct-care (primary) processes and indirect-care (support) processes.
The indirect-care processes include administrative, legal, financial, and regulatory sub-processes comprised
of tasks such as appointment scheduling, patient information documenting, retrieving and storing patient
health records, billings and claims processing, and communications. These processes provide core support
services but may not have a direct impact on the quality of care. On the other hand, the primary direct-care
clinical workflow consists of tasks like medical treatment (triage), recording patient history,
examination/assessment, developing a treatment plan, patient education, medication prescription, ordering
lab procedures, and clinical follow-ups (Bowens et al. 2010); these have a direct impact on the quality of
care and possibility of medical error. Typical errors recorded through medical malpractice claims include
errors in clinical judgment or patient assessment, diagnosis failures, treatment failures, medication errors,
communication failures, poor documentation, technical incompetence, and healthcare services
mismanagement.
Complications are an inherent possibility of any procedure or medical intervention (Helo and
Moulton 2017). An adverse event is an undesirable outcome and may be due to either an inherent complex
patient condition or a medical error arising from a system-based failure or an individual practitioner-based
failure. System-based failure includes documentation errors, medication errors, or non-conformity to
patient safety procedures and arises from process inefficiencies of the healthcare system at large. On the
other hand, practitioner-based failures can be either due to clinical assessment-related decision-failures,
including treatment and diagnosis failures, or professional negligence with failure to provide a standard
level of care resulting in an injury or infection due to the medical procedure.
Clinical

decision-making

critically

depends

upon

patient

information,

practitioner

knowledge/expertise, and practitioner experience. Lack of any one of these three may lead to decision error.
Skill-based errors result from an unexpected departure from familiar routine tasks performed by a medical
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practitioner due to memory failure, attention failure, or professional negligence. While memory failure or
attention failure may be caused by interruption or distraction from a task, professional negligence may
result from confidence over frequent engagement in repetitive tasks requiring minimal attention. Moreover,
medical error may also be due to intentional digression from policy, procedures, or standards of care.
Table 1.1: Different medical error types in malpractice claims and Meaningful Use of Health IT
Error types

Management
problems

Inadequate staffing,
inefficient management of
resource or operations

Equipment
failures

Defective warnings or
alarms and unavailable or
faulty equipment

System
based

Decision error

Memory
failure

Practitionerbased

Description

Attention
failure

Negligence

Violations

The wrong response to an
emergent situation, patient
assessment failure,
diagnosis failure, and
wrong treatment plan
selection
Memory lapse for all or
part of a procedure and not
following the checklist of
medical procedures for
adequate standards of care
Distraction or inattention
while engaging in a routine
familiar task, otherwise
requiring minimal attention
like safety and security
procedures, communication
protocols, and medication
management
Administering incorrect
dosage of medication or
anesthesia and/or
conducting medical
procedures incorrectly or
out of sequence
Intentionally not following
policy, procedure, or set
standards of care
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Examples of the
malpractice claim
Patient with vascular
occlusions required
bilateral leg
amputations with
unreasonably delayed
vascular consult
Second-degree burns
from malfunctioning
warming blanket used
intraoperatively

MU components
measured

CDR, CPOE, LIS,
HIE, PD, RIS

CDR, CPOE

CT scans mistakenly
read as kidney infection
led to delayed diagnosis
of appendicitis

CDSS

Retained foreign body
during surgery resulted
in infection and
additional surgery

EHR, CDSS

Complaints of pain
dismissed during IV
insertion

CDR, LIS, HIE,
CPOE, RIS

Surgical errors or
wrong-site surgery

CDR, HIE

Illegal access to
patient’s medical record
resulting in HIPAA
violation

HIE

Table 1.1 describes various medical error types from our malpractice claims dataset and helps us
in understanding the sources of these errors and what components of meaningful use of Health IT
components measured as part of MU attestation directly impact them. Many factors leading to medical
errors are related to informational issues. Meaningful use of EHR impacts the capture, storage, retrieval,
and access to patient health information. Health IT and its interactions with process workflows are expected
to impact medical errors. Based on the qualitative analysis of malpractice claims given in Table 1, types of
error, and Human Factors Analysis Classification System (HFACS) (Diller et al. 2014; Reason 2000), we
develop a framework that ties malpractice claims to medical errors through the adverse event in Figure 3.

Figure 1.3: Framework for Impact of HIT on Malpractice Claims
Figure 3 presents our conceptual model that connects the adoption of Health IT to the malpractice
claims process through the role of information in healthcare outcomes. Healthcare service delivery involves
information metabolism as different processes intake, transform, and/or produce information towards the
goal of the expected clinical outcome of improving and/or maintaining patients’ health statuses (Reid et al.
2005). Prior literature has provided support that the adoption of Health IT improves clinical outcomes by
impacting patients through a better quality of healthcare (Menon and Kohli 2013; Wani and Malhotra 2018)
and business value to healthcare organizations such as hospitals by improving profitability (Kohli and
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Devaraj 2008). While the prior research has primarily focused on patient outcomes and business-value
generation in healthcare organizations, in this study, our focus is on malpractice claims which directly
impact medical practitioners.
Medical malpractice claims signal underlying problems or latent medical errors that often have
severe consequences (Reason 1995). Health IT usage indirectly impacts the likelihood of occurrence of
these latent medical errors which may be practitioner-based failures and/or system-based failures. Thereby,
in our conceptualization, adoption of Health IT or certification of meaningful use impacts the malpractice
claims through the impact on practitioner-based and system-based failures leading to latent medical errors.
Based on the results from prior studies on the impact of Health IT on hospital and patient outcomes (Hydari
et al. 2019; Lin et al. 2019; Menon and Kohli 2013; Wani and Malhotra 2018), we found a reduction in
reported malpractice claims for those medical practitioners who demonstrate adoption of Health IT through
meaningful use certification. Since in the econometric analysis we found significant statistical support for
a reduction in malpractice claims due to the adoption of Health IT, we use thematic content analysis of
malpractice claims using topic modeling approach (Bao and Datta 2014; Huang et al. 2018) to get insights
on how Health IT lowers the likelihood of malpractice claims by reducing practitioner-based errors. This
would allow us to unbundle the pathway from Health IT usage to malpractice claims.
We develop hypotheses to investigate the impact of Health IT adoption and meaningful use on
malpractice claims risks. We propose the following hypotheses:
Hypothesis 1: MU-Stage-1 attestation by a medical practitioner has a negative effect on the likelihood of
a malpractice claim reported against the practitioner.
Hypothesis 2: MU-Stage-2 attestation by medical practitioners has a negative effect on the likelihood of a
malpractice claim reported against the practitioner.
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1.5

Data Description
In this section, we first describe five large data sources and our approach of matching records from

them to create the dataset for our analysis. Then in §4.1, we present model-free insights from our dataset
which help us in choosing an appropriate empirical strategy in §5.
We construct a unique panel data set consisting of a representative sample of eligible professionals
(EPs), that is, medical professionals licensed in Florida to practice, for the years 2009 to 2016 by collating
five large databases/datasets which individually contain information about different variables that are key
to our research. Below, we provide a brief description and source of these databases/datasets.
I.

Florida Office of Insurance Regulation’s Professional Liability Claims Reporting Database
(PLCR): The Office of Insurance Regulation (OIR) conducts oversight of one of the largest
insurance markets in the world and maintains the PLCR database. Insurers and/or self-insured
medical facilities doing business in the state of Florida electronically submit closed claims and
aggregate reporting information to the Florida Department of Financial Services (DFS). Each
insurer providing coverage for medical practice liability is required to report to the office any claim
or action for damages3 claimed to have been caused by error, omission, or negligence in the
performance of the medical services4 if the claim resulted in (a) a final judgment in any amount;
(b) a settlement in any amount; (c) a final disposition not resulting in payment on behalf of the
insured. It takes about 5-6 years for 96% of the lawsuits filed in a given year to be resolved (Holman

3

Section 627.912(1)(b), Florida Statute - the term "claim" means the receipt of a notice of intent to initiate litigation,
a summons and complaint, or a written demand from a person or his or her legal representative stating an intention to
pursue an action for damages against a person. The term "final disposition" means the insurer has brought down all
reserves and closed its file.
4
The Florida Medical Association cautions that the settlement of malpractice claims occurs for a variety of reasons,
which do not necessarily reflect negatively on the professional competence or conduct of the individual practitioner
or institution. Furthermore, liability claims information can be misleading because insurance companies may settle
claims for a variety of business reasons (FOIR 2020).
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et al. 2011). Collection of data was carried out in the year 2020, allowing a sufficient amount of
resolution to study the period of 2009-2016.
To retrieve relevant information from this database for our research, we query closed
claims which have “date of occurrence of injury” within the period of 01/01/2009 to 12/31/2016.
Since the basic query provides only a summary of claim records, to obtain detailed diagnostic
information from a very large number of records, we automated the process through python scripts.
This allowed us to collect diagnostic information from each claim record on the final diagnosis for
which treatment was sought including the patient’s actual condition, treatment procedure rendered
causing the alleged injury, severity, and details of the principal injury.
II.

Centers for Medicare and Medicaid (CMS) provided Medicare Practitioner Enrollment,
Chain, and Ownership System (PECOS) public-use data files: The Medicare program provides
health insurance for people 65 years of age and older, certain disabled people, and people with
kidney failure while Medicaid provides health insurance coverage for most medical expenses for
low-income women and children families, medical expenditures not covered by the Medicare
program for the low-income elderly, most medical expenses for the low-income disabled, and
nursing home expenditures of many of the institutionalized elderly (Lichtenberg 2006; Moffitt
2013). Healthcare professionals and hospitals must meet the eligibility criteria defined by law to
receive incentive payments for implementing EHRs in CMS programs. PECOS is an online
practitioner and supplier enrollment system, which contains basic practitioner information for those
who are eligible to bill Medicare under fee-for-service, such as national provider identifier (NPI),
practice location including city, state, and zip code; graduation year; gender; specialty; and the
reassignment of benefits information. The National Provider Identifier (NPI) is an Administrative
Simplification Standard under Health Insurance Portability and Accountability Act (HIPAA) and
is a 10-position, unique numeric identifier (10-digit number) for covered health care practitioners.
We filter the dataset for eligible practitioners enrolled in Florida based on the state code information
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and use the NPI as the primary key to obtain the data for all medical practitioners who are based in
Florida and are enrolled in CMS Medicare incentive programs.5
III.

CMS public-use data files for Meaningful-Use (MU) attestation: Centers for Medicare &
Medicaid Services (CMS) provides the most recent Medicare EHR Incentive Program Eligible
Professionals (EPs) Public Use File (PUF). Each PUF record provides the type and specialty of an
EP together with his/her responses to the meaningful use core and menu measures. This includes
attestation dates for Meaningful Use Stage 1 (MU-Stage-1) and Meaningful Use Stage 2 (MUStage-2) criteria. This dataset consists of records for all EPs in the US, and we filter the data
specifically for Florida, by first filtering records of Stage-1 unmodified, Stage-1 modified, Stage-2
unmodified, and Stage-2 modified and then merging the data using NPI as the primary key. Given
the size and complexity of the PUF dataset, to ensure the correctness of the filtered dataset for our
research, we repeated this exercise multiple times and verified that we get the same dataset for each
iteration.

IV.

Florida Department of Health’s Practitioner Profile Dataset: The official website6 contains
information about the location as well as profiles of EPs who are licensed to practice in Florida.
This dataset contains self-reported information from licensed EPs as specified under Section
456.041, Section 456.039, and Section 456.0391 of Florida Statutes (Laws).7 This dataset contains
information about each EP’s education and training, including other health-related degrees,
professional and post-graduate training specialty; current practice and mailing addresses; staff
privileges and faculty appointments; and reported financial responsibility. It also includes
information about any legal actions and the board’s final disciplinary action taken against the
practitioner.

5

This data does not include information on opt-out practitioners. Information is redacted where necessary to protect
Medicare practitioner privacy.
6
Website link: http://www.flhealthsource.gov/data-portal
7
The dataset contains information reported by EPs to the Division of Medical Quality Assurance as required by law
in Florida but reported information is not verified by the department.
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This dataset comprises 23 individual tables that were downloaded and merged using a
medical license as a key identifier for consolidated information. Medical license information was
not a field in the original data files and was created using the profession code and license number
fields in each table. This exercise was repeated twice to ensure the integrity of the consolidated
dataset. This dataset is a single time-invariant snapshot of the EP profiles practicing in Florida for
the entire duration of the period of this study, that is, 01/01/2009 to 12/31/2016.
V.

Center for Medical Services (CMS) National Plan and Practitioner Enumeration System
(NPPES) public-use data files: These data files are critical for putting together our master dataset
because we need to merge the above-mentioned four datasets wherein datasets 2 and 3 which are
from CMS have NPI as the primary key and datasets 1 and 4 which are from Florida state have
practitioner licenses number as the primary key. NPPES data files allow us to map NPI to
practitioner license number and thus help us in creating the master dataset for our research. This
dataset is particularly useful as it serves as a mapping tool for license numbers and NPIs. This
provides us the opportunity to combine all datasets previously mentioned into a large panel dataset.

In summary, our dataset comprises a representative sample of active medical practitioners in Florida,
during the observation period 2009-2016. For each medical practitioner, for each year, we observe the
number of malpractice claims filed and also the MU-Stage attestations. We obtain a final dataset for this
study which has 25,650 medical practitioners, and a balanced panel with 205,200 practitioner-year
observations. In our dataset, 3,865 medical practitioners faced one or more malpractice claims during the
observation periods; only 284 medical practitioners faced more than one malpractice claim within a year
anytime during the observation period.
1.5.1

Model-free Insights
Before describing our empirical strategy to address research questions, and keeping in view

econometric challenges, we first slice-and-dice data and present some insights from graphical analysis.
While Figures 4a to 4d present the population distribution of all medical practitioners, Figures 5a to 5d
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present the distribution of malpractice claims, and Figures 6a to 6d present the distribution of MU-Stage
attestation from the perspectives of gender, years of medical practice experience, faculty appointments, and
prior malpractice claims.

Figure 1.4a-d: Data description of medical practitioners in Florida

Figure 1.5a-d: Claims reported for sub-populations
The gender distribution of active medical practitioners in our dataset is skewed towards males with
almost twice as many males as females in the population. We find male medical practitioners are more
likely to attest to MU-Stages and have lower chances of claims being reported against them. The experience
distribution reveals resistance to attestation by more experienced practitioners and a higher likelihood of
claims being reported against them. This pattern observed in attestation had been explained with resistance
to technology adoption exhibited by more experienced professionals. The higher chances of claims being
reported against more experienced professionals can be attributed to the fact that with more experience,
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medical practitioners are burdened with the responsibility of handling extremely complicated medical
conditions which are more likely to result in an unfavorable outcome.
We also find, in our dataset, the professionals with AHCA disciplinary actions against them less
likely to go for MU-Stage attestations and more likely to have a claim reported against them. This behavior
indicates the presence of unobserved profile characteristics like conscientiousness affecting practitioner
behavior towards attestation as well as professional negligence with higher chances of claims being reported
against them. Practitioners with prior claims reported against them are more likely both to attest to MUStages and to have additional subsequent claims reported against them. This pattern relates to the exposed
vulnerability of a practitioner once a claim has been filed against them as established by prior literature.
Practitioners with prior criminal offenses are less likely to opt into the MU-Stage attestations, and they are
also less likely to have new claims reported against them. This observation can be explained by increased
awareness of their legal vulnerability and a more conscious effort to avoid any legal complications.
Although the practitioners who have served faculty appointments or have received awards are more likely
to attest to MU-Stages compared to their counterparts, the claim likelihood does not show much difference.
This observation is per general expectations. We also find additional certifications and degrees strongly
influence attestations to MU-Stages, while the chances of claims being reported also become higher.

Figure 1.6a-d: MU-Stage attestations for sub-populations
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1.5.2
1.5.2.1

Variables and Summary Statistics
Dependent Variable
According to prior research, malpractice claims are directly related to patient safety and quality of

care and are used to study clinical processes and adverse events (Kravitz et al. 1991; Rothschild et al. 2002).
The malpractice claims reported against practitioners are inversely related to the quality of care they provide
to their patients. We develop our binary outcome variable using publicly available information on claims
reported in Florida during the observation period of our study, 2009-2016. Our binary outcome variable,
ClaimReported, is true (assuming value 1) when the observed practitioner has at least one claim reported
against him/her with the date of occurrence of alleged injury in the observation year, otherwise false
(assuming value 0). The dependent variable measures whether a practitioner had any claims reported against
him/her due to any adverse events which originated during the observation year.
1.5.2.2

Independent Variables
The demonstrated Health IT capability of a practitioner is captured using MU-Stage attestation

records publicly provided by CMS for both MU-Stage-1 as well as MU-Stage-2 attestation. The attestation
trends among the observed medical practitioners are provided in Table 1.2.
Table 1.2: MU-Stage attestation trend of individual practitioners in Florida
Attestation
MU-Stage-1
MU-Stage-2
Total

Years
2011
2,354
2,354

2012
8,052
8,052

2013
10,749
10,749

2014
9,853
2,121
11,974

2015
5,226
7,210
12,436

2016
4,694
8,140
12,834

Table 1.3: Groups of practitioners based on attestation behavior
Group
Group-0
Group-1
Group-2
Total

Medical Practice Type of Practitioner
Diagnostics
1,456
349
867
2,672

Medicine
7,733
3,045
5,990
16,768
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Nursing-Care
2,383
32
9
2,424

Surgery
968
770
2,048
3,786

Total
12,540
4,196
8,914
25,650

The practitioner’s profile characteristics affect the behavior of the practitioner towards MU-Stage
attestations as well as qualities such as professional diligence, both of which affect the likelihood of
malpractice claims being reported against him or her. Table 1.4 and Table 1.5 describe the variables and
correlations in our study. Practitioner profile characteristic variables include experience, gender, number of
prior closed claims, number of AHCA disciplinary actions, number of criminal offenses registered, number
of awards received, number of certifications completed, and number of faculty appointments served. These
characteristic variables are related to the unobserved time-invariant effects only through their correlation
with ability and personality traits. The variable correlations (See Table 1.5) are not high enough to raise
concerns about multicollinearity issues in our empirical models, although some of the correlations are
statistically significant.
Table 1.4: Variable Description
Variable
ClaimReported

Description
Equals 1 if a claim was reported against the practitioner in the
observation year
Group
Practitioner’s group based on highest MU Stage attested to during the
observation period (Group-0 attested to none, Group-1 attested to MUStage-1, Group-2 attested to both MU-Stage-1 and MU-Stage-2)
Year
Year of observation (2009-2016)
Attested
Equals 1 if the practitioner has attested to either of the MU-Stages by the
observation year
AttestedGroup
Practitioners who attest to at least one MU-Stage during the observation
period
AHCADisciplinaryActions Number of AHCA disciplinary actions invoked against the practitioner
Certifications
Number of specialty certifications received by the practitioner
PriorClaims
Number of claims reported against the practitioner before 2009
CriminalOffenses
Number of criminal offenses reported against the practitioner
FacultyAppointments
Number of faculty appointments served by the practitioner
Awards
Number of awards received by the practitioner
Experience
Work experience in years after graduation until the year 2009
Gender-Male
Equals 1 if the gender of the practitioner is male, and 0 if female.
Type of practitioner’s medical service (Diagnostics, Medicine, NursingMedicalPracticeType
Care, Surgery)
The period during which MU-Stage-1 attestation was available (2011PostEventOne
2016)
The period during which MU-Stage-2 attestation was available (2014PostEventTwo
2016)
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Table 1.5: Variable Correlations
Variables
1 AHCADisciplinaryActions

1

2

3

4

5

6

1

2 Certifications

-0.0229*

1

3 PriorClaims

0.0984*

0.0276*

1

4 CriminalOffenses

0.0482*

-0.0484*

-0.0048*

1

5 FacultyAppointments

-0.0226*

0.1576*

-0.0131*

-0.0216*

1

6 Awards

0.0058*

0.0584*

0.0029

0.0078*

0.1711*

1

* significant p<0.05
Our study involves two events influencing the phased treatment. The first event is MU-Stage-1
attestation commencement in 2011 while the second event is MU-Stage-2 attestation commencement in
2014 as announced by CMS. We mark individual observations following these two events using binary
indicator variables PostEventOne and PostEventTwo as described in Table 1.4.
1.6

Econometric Model
Although experiments are ideal to uncover causal effects of treatment, our analysis relies on the

limited observational data sourced from varied public-use data files. In econometrics literature, some of the
most challenging empirical questions involve “what if” statements about counterfactual outcomes like the
ones related to the effect of career decisions in labor economics (Angrist and Krueger 1999; Imbens and
Wooldridge 2009). These questions are mostly inspired by direct policy concerns, theoretical deliberations,
and concerns of the individual decision-makers. On the same lines, we investigate a causal if-then question:
Do MU-Stage attestations make practitioners perform better? In other words, do medical practitioners who
attest to MU-Stages perform better, in terms of medical errors, in turn leading to a reduced risk of
malpractice claims, because of the attestation, or they would have performed better anyway?
The challenge of identifying causal effects of MU-Stage attestation on a practitioner’s professional
performance, as measured by malpractice claim likelihood, originates from the presence of unobserved
factors that influence both the treatment and the outcome. Specifically, we do not observe a practitioner’s
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professional conscientiousness, which is likely to affect both the self-selection into MU-Stage attestation
and the likelihood of medical error leading up to malpractice claims reported. Our empirical setting is
further complicated by the relatively rare occurrences of malpractice claims against practitioners whose
decisions to attest to MU-Stages are often linked to their professional diligence and conscientiousness. This
professional and personal characteristic also affects their malpractice claims likelihood, to begin with. The
attestation is voluntary, and practitioners self-select into the Health IT treatment leading to the selection
problem. The unobserved confounding factors and heterogeneity lead to endogeneity issues in model
formulation, rendering classic least square estimators inconsistent and biased. Estimating the effects of
treatment entails the necessity to account for both the non-random self-selection into attestation and the
endogeneity issues because of unobserved professional diligence and conscientiousness.
Recent empirical literature incorporates an increasing number of causal analyses of treatments in
labor market economics and health economics policy evaluations. We follow different econometric
approaches to control for selections on both observed and unobserved heterogeneity to evaluate treatment
effects (Angrist and Pischke 2008; Blundell and Costa Dias 2009; Cameron and Trivedi 2009; Imbens and
Wooldridge 2009; Wooldrige 2011). Extant literature measures the effect of the treatment by comparing
the average outcomes of the treated and nontreated groups. This comparison requires some assumptions,
such as the conditional independence assumption, that outcomes are independent of treatment; the
confoundedness assumption that selection into the treatment is independent of the potential outcomes with
and without treatment for same values of observable covariates (Imbens 2004); the ignorability assumption
(Rubin 1978) that treatment assignment ignores outcomes; and the conditional mean independence
assumption, that outcome of not receiving treatment does not determine treatment participation. These
assumptions are violated in our setting due to the presence of self-selection. In the empirical literature,
approaches to handle self-selection are divided broadly into two categories: ones that deal with selection
on observables, presuming that self-selection effects directly depend entirely on measurable observed
characteristics of the individual, and those which deal with selection on unobservables, presuming that
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unobserved, unmeasurable, individual characteristics drive self-selection. In our setting, self-selection
belongs to the second category of analyses.
1.6.1

Individual-Level Difference-in-Differences
As discussed earlier, our estimation strategy evaluates the change in the likelihood of a claim being

reported against a practitioner in response to Health IT usage or MU-Stage attestation. To validate this
approach, we need to understand how the practitioners who self-select into attestation at some point during
the observation period differ from those who never do that. Difference-in-Difference (DiD) estimation
methodology has been a popular method for estimating average treatment effects. This approach controls
for unobservables with the key underlying assumption of common trends which means that differences
between the treatment group and the control group would have remained constant in the absence of the
treatment. The common trends assumption, in our context, translates to the trend of claims reported against
the practitioner stays constant for all the practitioners except for their MU-Stage attestation.
Although this assumption can never be tested directly (Wing et al. 2018), there are several ways to
examine its plausibility. Additionally, our identification strategy might be threatened if other legal or policy
changes coincide with Meaningful Use incentive programs, which might either directly change the
practitioner’s professional behavior or might interfere indirectly via a personal attitude towards Health IT.
Since we have no information in the public domain of such external factors affecting the medical
malpractice liability system during the observation period of our study, we believe our analysis is well
identified. We provide details of robustness checks in §5.1.
In general, we consider an individual treated with Treatment-Level-1 if the practitioner ever attested to
MU-Stage-1 and Treatment-Level-2 if (s)he ever attested to MU-Stage-2. Once attested, from that pointin-time onwards, (s)he remains at that level of treatment. In other words, we assume that treatment to level1 or level-2 leads to a transition to another absorbing state. On the other hand, our control group consists of

32

medical practitioners who never attested to any of the MU-Stages. In summary, our dataset comprises three
distinct types of attestation behaviors:
1. Control Group: No Attestation
2. Treatment-Level-1: No Attestation  MU-Stage-1 attested
3. Treatment-Level-2: No Attestation  MU-Stage-1 attested  MU-Stage-2 attested
We group the practitioners based on their attestation behavior between 2009 and 2016 into the Control
Group, Group-1 (Treatment-Level-1), and Group-2 (Treatment-Level-2). We use the difference-indifference (DiD) approach to assess the causal effect of attestation by comparing Group-1 and Group-2
with the Control Group.
In the DiD estimator, the average reduction in the likelihood of malpractice claims being reported
against a practitioner over time in the control group is subtracted from the reduction over time in the
treatment group (Group-1 or Group-2). This double differencing removes inherent biases in the posttreatment comparisons, which could be the result of permanent differences between these groups, as well
as time trend biases unrelated to the treatment (Imbens and Wooldridge 2009). Moreover, we generalize
this framework to allow for general forms of heteroscedasticity by relaxing the full independence
assumption to mean-independence (Athey and Imbens 2006). We also control for individual-level
unobserved heterogeneity and self-selection problems by allowing for individual-specific fixed effects
being correlated with groups (Pfeifer et al. 2018).
Since non-linear models are difficult to interpret, we use the linear probability model (LPM) in our
study. Although the LPMs are characterized by reduced efficiency, fortunately, that is not of critical
importance to our analysis with a large number of observations in the sample. LPMs are unbiased and
consistent estimates of a variable’s average marginal effect on the probability of the binary outcome being
true and reasonable choice over non-linear regression approaches (Mood 2010; Wooldrige 2011). Also, we
estimate LPMs because the identifying assumption of the DiD approach is linear. To correct for serial
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correlation due to repeated units of observation in our dataset, we obtain clustered heteroscedasticity-robust
standard errors (Pischke 2005).
We estimate the following two econometric models with the DiD approach for MU-Stage-1
attestations made available by CMS in the year 2011 (Treatment-Level-1) and MU-Stage-2 attestations
which were made available in the year 2014 (Treatment-Level-2). Although both Group-1 and Group-2
undergo the Treatment-Level-1 event, only Group-2 undergoes the Treatment-Level-2 event. We combine
Group-1 and Group-2 into a common Attested-Group for the Treatment-Level-1 model given below:

ClaimReportedit  01  11 AttestedGroupi  1PostEventOnet  1 AttestedGroupi  PostEventOnet

(3)

  ProfileCharacteristicsit  it
The Treatment-Level-2 model equation for Group-2 with the second event is given below:

ClaimReportedit  02  12Group2i  2 PostEventTwot  2Group2i  PostEventTwot
 ProfileCharacteristicsit  it

(4)

where PostEventOne and PostEventTwo are time-indicators for applicability of Treatment-Level-1
and Treatment-Level-2. We are interested in the estimates of DiD-coefficients 1 and  2 , which provide
us with the causal effect of MU-Stage-1 and MU-Stage-2 attestation within the sample population. We
present our results for all three models in the next section.
1.6.2

Robustness Checks
As part of robustness checks, we test whether effects appear before the MU-Stage incentive

program roll-out (Pfeifer et al. 2018). To investigate this matter, we include a placebo indicator,

PostPlacebot , to Equations 3 and 4, that is, we assign treatment status as if the Treatment-Level-1 and
Treatment-Level-2 had been introduced in 2010. We exclude the period after the MU-Stage attestations
came into effect, specifically years after 2011 for MU-Stage-1 and years after 2014 for MU-Stage-2, for
this placebo test. More formally, for a robustness check, we estimate the following models:
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ClaimReportedit  01  11 AttestedGroupi  1PostPlacebot  1 AttestedGroupi  PostPlacebot
  ProfileCharacteristicsit  it
ClaimReportedit  02  12Group2i  2 PostPlacebot  2Group2i  PostPlacebot
 ProfileCharacteristicsit  it

(5)

(6)

Furthermore, we relax the common trends assumption including group-specific linear time trends in an
augmented specification to check whether our results are robust to the inclusion of these trends. We discuss
these robustness checks with interacted fixed effects in the next section.
1.7

Results
In this section, we discuss the results from the two models described by equations (1)-(4) presented

in §5. Before correcting the endogeneity problem, we first use the dataset to estimate equation (1) using
logistic regression. In all these models, year indicators are included to account for the common time-specific
trends and external shocks experienced by all the medical practitioners during the observation period.
Standard errors were obtained by heteroscedasticity-robust clustering on National Provider Indexes (NPIs)
to correct for serial correlations as discussed earlier. The Wald-test results indicate significant endogeneity
between the main and selection equations.
The estimated average marginal effects from single equation logit regression are displayed in column
(1) of Table 1.6. The incidence of a claim being reported against a practitioner, ClaimsReported, is
positively associated with the variable Attested which measures Health-IT treatment via MU-Stage
attestations. This effect shows high statistical significance also. This indicates that all else constant, the
likelihood of a malpractice claim reported against a medical practitioner who attests to MU-Stage is higher
compared to one who does attest. This result appears contrary to prior literature which has reported a
positive effect of the adoption of Health IT on quality of care as well as lowering of malpractice claim
premiums (Hydari et al. 2019; Lin et al. 2019; Menon and Kohli 2013; Wani and Malhotra 2018). Note that
this estimation approach does not account for the possibility of initial differences in the likelihood of
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malpractice claims between those who self-selected into attestation and those who did not. Regarding other
variables, the estimated effect of Experience is negative, indicating approximately 0.02 percentage points
of reduction in the probability of a claim being reported against a practitioner with each additional year of
experience, ceteris paribus. Also, there is an annual trend of a 0.22 percentage points reduction in claims
reported, with males almost 0.99 percentage points more likely to be reported in a malpractice claim than
their female counterparts.
Table 1.6: Logistic Model Results (Average Marginal Effects)
VARIABLES
Medical Practice Type (Base: Surgery)
Diagnostics
Medicine
Nursing-Care
Experience

Logistic Model
-0.0035**
(0.0015)
-0.0105***
(0.0011)
-0.0247***
(0.0014)
-0.0002***
(0.00004)
-0.0022***
(0.00018)
0.0099***
(0.0010)
0.0019**
(0.0009)
0.0233***
(0.00086)
0.0048**
(0.00214)
-0.0042**
(0.00191)
0.0023***
(0.00044)
-0.0007**
(0.00031)
-0.0032***
(0.00071)

Year
Gender-Male
Attested
PriorClaims
AHCADisciplinaryActions
CriminalOffenses
Certifications
Awards
FacultyAppointments
Observations

205,200

Rho (ρ)

-

Wald tests of rho=0 significant at 1% level indicating the presence of significant endogeneity for all models
Robust standard errors in parentheses *** p<0.01, ** p<0.05, * p<0.1
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Although practitioner profile characteristics like PriorClaims, AHCADisciplinaryActions,
FacultyAppointments, and Awards have expected marginal effect directions, CriminalOffenses and
Certifications have surprisingly opposite directions of effect. We find the practitioners with prior reported
malpractice claims have 2.33 percentage points higher claim likelihood than those without. Similarly,
practitioners with AHCA Disciplinary actions against them have a 0.48 percentage points higher likelihood
of malpractice claims reported against them.
We need to investigate the nature of heterogeneity between the treatment and the control group.
We have claims data for the practitioners for the years 2009-2010, when there was no MU-Stage attestation
program available from CMS. We sub-divide our population into two subgroups based on whether they
chose to attest or not attest to MU-Stage(s) anytime during 2011-2016. We then examine the population
proportion of practitioners with claims reported against them for these sub-groups over the years in Figure
7. We observe that the practitioners who self-selected into attesting to MU-Stage(s) originally had a higher
likelihood of claims being reported against them even before the program was introduced by CMS in 2011.
This has important implications for our empirical strategy since there are pre-existing differences in the
likelihood of malpractice claims being reported between the practitioners who self-select into treatment
(MU-Stage attestation) and those who do not.

Providers with Claims

Claims Proportions
2.00%
1.50%
1.00%
0.50%
0.00%
2009

2010

2011

2012

2013

2014

2015

2016

Years
Control-Group

Treatment-Group

Figure 1.7: Claim-proportion trends in attested v. non-attested practitioners
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These differences are contrary to expectations as practitioners who self-select into the treatment are
the ones who are more likely to have malpractice claims reported against them. This situation draws a
parallel from the classic example of the sick seeking treatment. Although the sick are the ones who visit
hospitals more often than the healthy ones, the effect of hospital treatment would appear to be negative if
one does not account for the original difference between the populations along with endogeneity correction.
Table 1.7: DiD Model Results for MU-Stage-1 and MU-Stage-2 Attestation Treatments
MU-Stage-1
Model-1
Model-2

Variables
Medical Practice Type (Base: Surgery)
Diagnostics

-0.00589***
(0.00165)
-0.0125***
(0.00125)
-0.0230***
(0.00134)

Medicine
Nursing-Care
Treated-Group
Post-Event
Treated-Group # Post-Event (DiD)
Experience
AHCADisciplinaryActions
PriorClaims
CriminalOffenses
Certifications
FacultyAppointments
Awards
Constant
Observations
Number of NPIs

MU-Stage-2
Model-3
Model-4

0.00709***
(0.00145)
-0.00553***
(0.00105)
-0.00359**
(0.00162)
-0.000164***
(3.51e-05)
0.00763**
(0.00320)
0.0697***
(0.00219)
-0.00284***
(0.00105)
0.00293***
(0.000455)
-0.00220***
(0.000592)
-0.000636**
(0.000266)
0.0172***
(0.00116)

0.00379**
(0.00148)
-0.00553***
(0.00105)
-0.00359**
(0.00162)
-0.000178***
(3.50e-05)
0.00697**
(0.00319)
0.0682***
(0.00218)
-0.00220**
(0.00104)
0.00215***
(0.000464)
-0.00286***
(0.000596)
-0.000630**
(0.000262)
0.0313***
(0.00170)

-0.00473***
(0.00180)
-0.0114***
(0.00136)
-0.0222***
(0.00143)
0.00579***
(0.00100)
-0.00712***
(0.000860)
-0.00275*
(0.00149)
-0.000171***
(3.80e-05)
0.00855**
(0.00386)
0.0685***
(0.00247)
-0.00366***
(0.00109)
0.00292***
(0.000498)
-0.00240***
(0.000623)
-0.000718***
(0.000273)
0.0161***
(0.000941)

205,200
205,200
171,632
25,650
25,650
21,454
Robust standard errors in parentheses *** p<0.01, ** p<0.05, * p<0.1

0.00238**
(0.00104)
-0.00712***
(0.000860)
-0.00275*
(0.00149)
-0.000181***
(3.79e-05)
0.00762**
(0.00383)
0.0670***
(0.00246)
-0.00284***
(0.00109)
0.00226***
(0.000506)
-0.00312***
(0.000629)
-0.000684**
(0.000269)
0.0289***
(0.00164)
171,632
21,454

Since the positive marginal effects of the BPM model estimations for the treatment variable
Attested do not account for initial differences between the two groups of practitioners, and therefore, are
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not able to capture the effect experienced by the treatment group due to treatment. The estimates only
indicate a higher likelihood of malpractice claims against the practitioners who attested compared to those
who did not. This inference is confirmed by the claims-proportion trends observed in Figure 7. The
treatment group of practitioners has a higher claims proportion at the beginning which remains higher than
that of the control group by the end of the observation period, even though the difference between the two
groups has significantly reduced over time. Therefore, to estimate the treatment effects, we rely on our
second empirical model – the DiD approach as presented in §5.2. We capture the unobserved heterogeneity
within the sample through the econometric approach of Differences-in-Difference (DiD) estimation.
The coefficient estimates of Equations 3 and 4 of DiD models are presented in Table 1.7 for the first
treatment of MU-Stage-1 attestations and the second treatment of MU-Stage-2 attestations. In Table 1.7,
Model-1 and Model-3 report result in the absence of controls for medical practice type while Model-2 and
Model-4 include medical practice type controls. We observe that the DiD coefficients (Treated-Group #
Post-Event (DiD)) in both the models (without and with practice type controls) for MU-Stage 1 as well as
for MU-Stage 2 are negative, consistent, and are significant at the same level. This implies that the DiD
coefficient estimates are robust to the specialty of medical practice and the DiD estimates are valid (Pfeifer
et al. 2018; Wing et al. 2018).
From the coefficient estimates of Equations (3) and (4) given in Table 1.9, we see that the
coefficient for the DiD-indicator (Treated-Group # Post-Event) is negative and statistically significant in
both the models' specifications. The MU-Stage-1 attestations rolled-out by CMS in 2011 exerted a negative
impact on the likelihood of malpractice claims reported against practitioners who attested for stage 1.
Quantitatively, the practitioners who attested to MU-Stage-1 observed, on average, an additional decrease
in the probability of a claim being reported against them by around 0.36 percentage points compared to the
control group of medical practitioners who did not attest. Given that the time trend decline of control and
treatment groups is similar for the period 2009 to 2014 (common trend assumption) and is 0.553%
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(coefficient of Post-event in Table 1.9), relatively, this additional decline of approximately 65% is due to
attestation to MU-Stage 1.
Furthermore, the practitioners who attested to MU-Stage-2 observed, on average, an additional
decrease in the probability of a claim being reported against them by around 0.27 percentage points
compared to the control group of medical practitioners who did not attest. Given that the time trend of
control and treatment groups is similar for the year 2009 to 2016 (common trend assumption) and is 0.753%,
relatively, this additional decline of around 35% is due to attestation to MU-Stage 2.
The DiD coefficients in models 2 and 4 (Table 1.9) estimate the reduction (because the coefficients
are negative) at risk of malpractice claim with reference to the surgery specialty (base specialty). The
specialties of diagnostics, medicine, and nursing each observe an additional decrease of around 0.59, 1.25,
and 2.30 percentage points with the MU-Stage-1 attestation, and an additional decrease of around 0.47,
1.14, and 2.22 percentage points with the MU-Stage-2 attestation, respectively. Moreover, medical
practitioners in specialties of medicine and nursing-care experience a relatively lower risk of malpractice
claims compared to the practitioners in surgery and diagnostics specialties.
A careful look at the other control variables like faculty appointments, criminal offenses, and
awards reveals the statistically significant negative effect of these on the likelihood of a malpractice claim
incident. Although faculty appointments and awards follow general expectations, the criminal offense has
a surprising effect which may be explained by a reduction in practice time when charged with a criminal
offense. AHCA disciplinary actions and prior claims have a positive coefficient, indicating that both these
variables are associated with a higher malpractice claim likelihood. This finding is not surprising as several
studies indicate that the practitioners who have prior malpractice claims are more susceptible to malpractice
claims in the future (CRICO Strategies 2015). We also observe that for each additional year of experience,
the probability of a malpractice claim incident against the practitioner tends to slightly decline, by around
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0.018 percentage points. These results are interesting as well as insightful and necessitate validation with
strong robustness checks.
1.7.1

Robustness Checks
In this subsection, we provide additional analysis to test for the validity of our main empirical

method of Difference-in-Difference (DiD) by checking the underlying identifying assumptions. DiD
designs assume that confounders varying across the treatment and control groups are time-invariant and
that time-varying confounders are group invariant (Wing et al. 2018; Wooldrige 2011). These twin claims
together are known as the common trend assumption. Since these assumptions cannot be directly tested,
following literature, we employ graphical analysis and statistical tests to empirically probe the credibility
of the assumption (Wing et al. 2018).
Table 1.8: Augmented DiD Model Results
VARIABLES

Treatment-Level-1
Augmented Eq (3)

Treatment-Level-2
Augmented Eq (4)

-0.00432*
(0.00236)
0.00165
(0.00220)
0.00311
(0.00235)
0.00140
(0.00213)
0.00115
(0.00196)
0.00280
(0.00186)
0.000866
(0.00170)

-0.00584**
(0.00279)
0.00136
(0.00270)
-0.000976
(0.00274)
-0.00174
(0.00280)
-0.00464
(0.00288)
0.00445*
(0.00227)
0.00122
(0.00208)

Yes
Yes
Yes

Yes
Yes
Yes

3.89
0.6812

7.96
0.2407

DiD Coefficient (β)
Group#(t=1)
Group#(t=2)
Group#(t=3)
Group#(t=4)
Group#(t=5)
Group#(t=6)
Yearly fixed effects
Group-Specific fixed effects
Individual-Specific fixed effects
F-test for compound null
chi2 (6)
Prob > chi2

Robust standard errors in parentheses *** p<0.01, ** p<0.05, * p<0.1
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As part of graphical analysis, we plot the mean outcomes by group on the y-axis and periods on the
x-axis. If the lines representing each group appear to be approximately parallel, then we have evidence to
support the common trend assumption (Wing et al. 2018). For this, we refer to Figure 7 in §3.1. We observe
almost parallel trends in the sample proportion of practitioners with claims reported against them for the
control group (who never attested) and the treatment group (who attested) in Figure 7 through the years
2009-2016. The plot in Figure 7 provides preliminary graphical evidence in support of the common trend
assumption, and below we perform a widely used statistical test to further confirm the validity of this
assumption.
An empirical statistical test for evaluating the common trend assumption includes fitting an
augmented DiD regression that allows for group-specific linear trends (Hansen et al. 2017; Wing et al.
2018). We augment Equations (3) and (4) in §4.2 with each group effect interacting with the linear time
index t , namely 11  AttestedGroupi * t  in (3) and 12  Group 2i * t  in (4), in addition to group and
period effects. F-tests of the compound null in which all the coefficients of the group-specific linear trends
in each new augmented equation, specifically 11 ’s and 12 ’s, are jointly zero, are tests of the common
trends model (Hansen et al. 2017; Pfeifer et al. 2018; Wing et al. 2018). Rejecting the null hypothesis would
lead to rejecting the validity of the common trend assumption. We present estimated coefficients of the
group-specific linear trends along with the results of F-Tests in Table 1.10. We observe that the F-Tests of
the compound null of the coefficients of interest in these models are not significant and thereby we fail to
reject the null. This strengthens the credibility of the common trends assumption of DiD in our context.
To address concerns regarding the influence of potential technological measures introduced by practitioners
before the official policy intervention of MU attestation on our estimated treatment effects, we perform
placebo tests as discussed in §4.2 to check if the treatment effects were present before the policy
intervention by assigning treatment status as if Treatment-Level-1 and Treatment-Level-2 had been
introduced in 2010. We provide results of Equations (5) and (6) estimations in Table 1.11. These placebo
models do not include data from the years after the program came into effect, specifically after the MU42

Stage-1 attestation (2011) for Treatment-Level-1 and MU-Stage-2 attestation (2014) and Treatment-Level2. We observe that no placebo effect is statistically significant. These findings further strengthen our
inference that the common trends assumption is not violated in our context, hence the results from using
the DiD method are robust and reliable.
Table 1.9: Placebo DiD Model Results
VARIABLES
Group # Placebo-Event
Observations
Number of NPIs

Treatment-Level-1
Eq (5)

Treatment-Level-2
Eq (6)

0.00154
(0.00287)

-0.00210
(0.00257)

205,200
25,650

171,632
21,454

Robust standard errors in parentheses *** p<0.01, ** p<0.05, * p<0.1

We address a critical concern arising due to data limitation. Our data consists of malpractice claims
for which the alleged negligence by EP occurred from 2009 to 2016, and the claims were closed by the end
of the year 20208. This implies that those malpractice claim adverse events which occurred during the 2009
to 2016 period but were not resolved by the end of 2020, will be missing in our dataset. Usually, it takes
about 5-6 years for 96% of the lawsuits filed in a given year to be resolved (Holman et al. 2011). If the
claim resolution time is lower for MU attested EPs compared to those who are not certified, then our
estimates will be conservative due to the dataset having relatively more claims of MU attested EPs. On the
other hand, if the malpractice claim resolution time for MU attested EPs is longer than those who are not
certified, then our dataset will have a lower number of claims for MU attested EPs than the true number
leading to overestimates of the effect of attestation. In other words, it would translate into the risk of
witnessing a reduction in malpractice claims primarily because those claims remain pending resolution.

8

Closed claim is a claim which has either been abandoned, settled, or disposed through a legal process.
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Figure 1.8: Claim Resolution Times for Treatment Groups
A simple plot of average resolution times of malpractice claims for the different groups of providers
is presented in Figure 1.8. The malpractice claim resolution time for those practitioners who choose to attest
for either of the MU stages is similar to those who choose not to attest. We expect that the resolution time
may be slightly lower for MU attested EPs (Ransbotham et al. 2020) and therefore, this data limitation will
only lead to conservative estimates of the causal effect of integration of HIT with clinical practice on
lowering the risk of a malpractice claim.
Table 1.10: DiD Model Robustness Check for MU-Stage-1 Attestation Treatment
Model-1
Restricted until 2014
Medical Practice Type (Base: Surgery)
Diagnostics
-0.00506***
(0.00195)
Medicine
-0.0125***
(0.00146)
Nursing-Care
-0.0229***
(0.00159)

Model-2
Restricted until 2015

Model-3
Restricted until 2016

-0.00523***
(0.00177)
-0.0121***
(0.00134)
-0.0226***
(0.00144)

-0.00589***
(0.00165)
-0.0125***
(0.00125)
-0.0230***
(0.00134)

0.00339**
(0.00149)
-0.00313***
(0.00112)

0.00362**
(0.00148)
-0.00433***
(0.00108)

0.00379**
(0.00148)
-0.00553***
(0.00105)

-0.00332*
(0.00172)
-0.000165***
(4.15e-05)
0.00839**
(0.00384)
0.0807***
(0.00274)

-0.00342**
(0.00166)
-0.000179***
(3.79e-05)
0.00795**
(0.00351)
0.0748***
(0.00241)

-0.00359**
(0.00162)
-0.000178***
(3.50e-05)
0.00697**
(0.00319)
0.0682***
(0.00218)

Variables

Treated-Group
Post-Event
Treated-Group # Post-Event (DiD)
Experience
AHCADisciplinaryActions
PriorClaims
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Table 1.10 (Continued)
CriminalOffenses
Certifications
FacultyAppointments
Awards
Constant
Observations
Number of NPIs

-0.00165
(0.00123)
0.00236***
(0.000540)
-0.00313***
(0.000696)
-0.000822***
(0.000299)
0.0296***
(0.00192)

-0.00199*
(0.00115)
0.00216***
(0.000496)
-0.00286***
(0.000638)
-0.000702**
(0.000275)
0.0302***
(0.00179)

153,900
179,550
25,650
25,650
Robust standard errors in parentheses *** p<0.01, ** p<0.05, * p<0.1

-0.00220**
(0.00104)
0.00215***
(0.000464)
-0.00286***
(0.000596)
-0.000630**
(0.000262)
0.0313***
(0.00170)
205,200
25,650

We perform DiD estimations of Eq (1), that is for MU Stage-1 attestation, by restricting data for
malpractice claims only up to 2014 and 2015 and report the results in Table 1.10. We find that the
directionality of results is consistent with that of the main results presented in Table 1.7. This further
provides additional support for our main result that MU Stage attestation lowers the risk of a malpractice
claim.
We found that the likelihood of malpractice claims and the probability of medical errors gets reduced
with an increase in demonstrated Health IT capability measured through meaningful use attestation. Several
robustness checks established the validity of our results, thereby providing strong evidence that Health IT
capability directly benefits medical practitioners by lowering the likelihood of a malpractice claim through
complex indirect mechanisms.
1.8

Tracing pathways - Thematic Content Analysis
In §1.6, we find significant statistical support for the causal inference that adoption and meaningful

use of Health IT leads to a reduction in the risk of malpractice claims against medical practitioners. While
the empirical results in § 1.6 are robust and are new in IS literature that focuses on the impact of Health IT
on medical practice (Lin et al. 2019; Menon and Kohli 2013; Wani and Malhotra 2018), the unsupervised
textual analysis of the malpractice claim-record documents may allow us to trace the pathway and uncover
the latent mechanism through which Health IT use reduces malpractice claims. To uncover the plausible
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pathway, in this section we explore the pathways from Health IT usage to malpractice claims through
thematic content analysis of malpractice claims. We use a topic modeling approach (Bao and Datta 2014;
Huang et al. 2018) on the corpus of documents consisting of malpractice claims filed in the State of Florida
from 2009 to 2016 to discern changes in the distribution of topics in pre-and post- MU-Stage certification
claims and then infer insights about the pathways by using the human-in-loop approach (Chang et al. 2009;
Towne et al. 2016) to relate topics to different aspects of clinical practice. This analysis may provide
qualitative support for our conceptual model in Figure 3.
We extract meaningful topics from the claim-record details to explore the latent topic representation
of the corpus, following the work of Bao and Datta (2014) and Huang et al. (2018). We use the topic
modeling method called Latent Dirichlet Allocation (LDA) (Blei et al. 2003). While there are many variants
of probabilistic topic modeling methods available such as Bi-Term Topic Model, Correlated Topic Model,
etc. (Xun et al. 2017; Yan et al. 2015), we use LDA for its better performance concerning human evaluations
of semantic meaning in inferred topics and its wide use in the research literature (Chang et al. 2009; Towne
et al. 2016).
Before applying the LDA algorithm to our collection of claim records, we assigned each claim to a
category based on the date of occurrence of the injury and the MU-Stage attestation history of the
practitioner against whom the claim was filed. This way each malpractice claim was assigned to either preattestation or post MU-Stage-1 attestation or post MU-Stage-2 attestation category. After the assignment
of each malpractice claim record to a category, we ran the text preprocessing steps of stemming and stopword removal on the collection of texts in claim details. We dropped 220 claim records out of 5183 claim
records after text preprocessing if those records had fewer than three words in the in-text details. Then, we
used log-likelihood and perplexity scores which measure the models’ ability to predict word choices in the
test data using the model estimated on training data to estimate the optimum number of topics for each
category of malpractice claim records. We keep the α and β hyperparameters of the LDA model fixed at
0.1 and 0.01. The perplexity score and log-likelihood for topic numbers ranged from 2 to 100 (Figure 8),
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and since the perplexity score tapers off around 20 topics, we assigned the total number of topics for our
model as 20 (Blei et al. 2003).
The LDA model gives us distributions of topics within each individual claim record. We combine
the distributions to form mixture distributions (Blei et al. 2003) of topics within a category of malpractice
claim records wherein the category depends on MU-Stage-level attestation. Since mixture distributions are
also useful for modeling subpopulations (Griffiths et al. 2004; Huang et al. 2014), grouping malpractice
claims in categories based on the MU-Stage-level attestation serves as the subpopulations of the entire
malpractice claims corpus. The document-topic distribution 𝜃 obtained from LDA represents the spread of
topics 1:K in documents 1:D (claim-records). Specifically, after obtaining the trained topic model, we
created the subset of the outputted document-topic matrix 𝜃 based on the document d belongs to which
MU-Stage-level. We then use linear pool, where the weights for each document are the same, specified by

𝑃 𝜃

:

,

=

1
𝜃
𝐷

,

(3)

to obtain the distribution of topics 1:K over each claim-subset 1: 𝐷 the Document-Topic matrix 𝜃 .
Equation (3) represents the probability of topic k in the claims subset 1: 𝐷 for claim n. We thereafter
obtained mean topic probability distributions for each subset of claim records.

Figure 1.9: Perplexity scores and number of topics for LDA models trained on claims-data
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The LDA model also provides the term-distribution within each topic as well as document-topic
assignments. Since the topic model’s latent space primarily originates from the medical domain,
interpretation of a collection of terms in a topic is not useful to carry out the human evaluation. Sampled
case details provide a better context for human interpretation. Following prior literature, we use the humanevaluation task approach for measuring semantic meaning in inferred topics obtained from probabilistic
topic models (Chang et al. 2009). We design a human-evaluation task for the topics inferred from the topicmodeling of unsupervised analysis of the text of malpractice claims.
Our human-evaluation task creates a formal setting in which humans inspect the latent space of our
topic model and evaluate whether a topic and the documents identified with that topic are associated with
system-based error or medical practitioner-based error. Since case details provide better context for human
interpretation, we select two subjects to perform the human-evaluation task9 and provide each one of them
with three malpractice claim records relating to each of the inferred topics and ask them to classify each
inferred topic, as either a system-based error or a medical practitioner-based error, based on the description
we provided for each error type. As discussed in § 3, system-based errors include documentation errors,
medication errors, or non-conformity to patient safety procedures; they arise from process inefficiencies
within the healthcare system, such as in hospitals. Practitioner-based errors can be due either to clinical
assessment related decision-failures, including treatment and diagnosis failures or to professional
negligence with a failure to provide a standard level of care, resulting in an injury or infection due to the
medical procedure.
The two subjects independently classify the claims as system-based errors or practitioner-based
errors. We then obtain the intersection of these classifications to obtain a common agreement on

9

A human-evaluation task in the context of topic modeling refers to interpretation of topics obtained through topic
modeling using human judgment (Chang et al. 2009). Following Chang et al. 2009, we design our humanevaluation task to identify if a topic extracted from a malpractice claim is related to a practitioner-based failure. We
pool three documents (claim-records) per topic with the highest probability for that topic into a randomized pool.
Then we request human evaluators to manually classify the documents into two groups based on their assessment of
whether the details within the claim relate to practitioner-based failure or not.
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classifications. Topics with more than 75 percent of sample claims marked with practitioner-based errors
are labeled as practitioner-based error topics. We observe the change in average topic probabilities for these
topics to capture the effect of the MU-Stage-level of demonstrated Health IT, on the type of claims and
practitioner-based errors.

Topic Probability Distribution
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Figure 1.10: Topic probability distribution for malpractice claims
We observe the change in average topic probabilities for these topics to capture the effect of MUStage-level certification (the level of adoption of Health IT) on medical practitioner-based errors. Based on
the result of the human evaluation task, we classify topics 1, 5, 6, 13, 14, 15, 17, and 19 as relating to
medical practitioner-based error and other topics to system-based error.
Figure 1.10 presents the topic probabilities for topics related to practitioner-based errors for
malpractice claim records in pre attestation (Stage-0), MU-Stage-1 (Stage-1) attestation, and MU-Stage-2
(Stage-2) attestation. We observe that topics related to a practitioner-based error, on average, experience a
reduction in occurrence probability with an increased level of MU-Stage attestation. This analysis
qualitatively shows that with the increased use of Health IT (higher stage attestation) medical practitioners
are likely to make fewer medical errors, leading to a lower probability of malpractice claims.
We inspected these topics relating to practitioner-based error further to find differences between
claims of practitioners who attested to MU-Stages over the years and those who did not. Figure 1.11
illustrates that the MU-Stage attestations over the years significantly reduce the average probability of
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topics relating to practitioner-based errors in malpractice claim records. This indicates that the average
probability of practitioner-based error in malpractice claim records decreases over the years.

Figure 1.11: Topic probability distributions for practitioner-based errors
To further understand the effect of the level of MU-Stage attestation (a proxy for the intensity of
use of Health IT) on practitioners, we analyze malpractice claim records of practitioners who attested only
to MU-Stage-1 and those who attested to both MU-Stage-1 and Stage-2 (Figure 1.12). While we see a
reduced probability of practitioner-based error topics with MU-Stage-1 attestations, we observe further
reductions with MU-Stage-2 attestations for most of these topic probabilities. This allows us to get insights
into the process through which the meaningful use of Health IT impacts practitioner-based errors.
Health IT components such as EHR, CPOE, and CDSS play a significant role in these reductions
observed in practitioner-error occurrences as captured in topic-probability distributions. For example, EHR
systems provide reminders and alerts along with intelligent capabilities for practitioners’ support. CPOE
systems mechanize the drug prescription process with additional readability and accuracy along with
standard instructions reducing medical prescription errors by around 80% (Kaushal et al. 2003). These
systems are effective in providing relevant lab results and alerting for allergies, drug-drug interventions,
proper dosing, and appropriate medication sequencing (Bates et al. 1999). CDSS protects incomplete
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information about patients and/or drugs leading to medical errors (Kaushal et al. 2003). It reduces
medication errors, adverse drug effects, nosocomial infection rates, and more through alerts, reminders, and
evidence-based standards and guidelines (Hunt et al. 1998). MU-stage attestations provide a benchmarking
for certified use of these components and thereby affect the practitioner-based errors which are captured in
topic probability distributions of malpractice claim records.

Figure 1.12: Topic probability distributions of practitioners based on MU-Stage attestation
behavior
1.9

Discussion and Conclusion
This study estimates the causal impact of meaningful use of Health IT, stimulated by the HITECH

Act of 2009, on the risk of medical malpractice claims. Further, if the impact of adoption and use of Health
IT on the risk of malpractice is negative, then we must explore the plausible mechanism through which
Health IT may be impacting the risk of malpractice claims. This mechanism may be through an impact on
latent medical errors embedded in malpractice claims. Furthermore, patient safety is closely related to
medical errors. Leveraging the EHR Incentive Program10 of the Center for Medicare and Medicaid Services
(CMS) allows us to quantify the meaningful use of Health IT by medical practitioners and with the

10

Now it is also known as Promoting Interoperability Program
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Professional Liability Claims database of the State of Florida, we construct a large dataset of Medicareenrolled medical practitioners licensed within Florida during 2009-2016.
Our econometric strategy consists of a Bivariate Probit model and the DiD model. Since the critical
assumption that the explanatory variables in the treatment selection equation are conditionally independent
of unobserved endogenous effects does not hold in our context, the estimates from the Bivariate Probit
model have less reliability compared to those from the DiD model. The results from our DiD analysis show
that meaningful use of Health IT by medical practitioners through MU-Stage1 and MU-Stage2 attestation
leads to a reduction in the likelihood of malpractice claims. More specifically, we find that the relative risk
of malpractice claims declines by approximately 29% with successful attestation to MU-Stage-1 and
additionally by approximately 22% with subsequent attestation to MU-Stage-2. We find practitioners in
medicine experience lower malpractice claim likelihood by around 0.6 percentage points while those in
nursing-care experience lower likelihood by around 1.7 percentage points, in comparison to diagnostics. In
contrast, practitioners in surgery experience a 0.5 percentage points higher likelihood of malpractice claim
incidents as compared to diagnostics.
Additionally, we unbundle the intrinsic mechanisms through which Health IT reduces the risk of a
malpractice claim by using thematic content analysis of the malpractice claims. Topic modeling (Bao and
Datta 2014; Huang et al. 2018) coupled with human evaluation and judgment (Chang et al. 2009; Towne et
al. 2016) provides deeper insights into the pathways of the impact of Health IT adoption and meaningful
use on the likelihood of malpractice claims. The latent themes revealed in the topics indicate the
practitioner-based errors registered a decline with increased meaningful use of certified EHR technology.
These results support our conceptual model and help us understand the intricacy of Health IT use in medical
practice which is the first step in improving IT efficacy within the healthcare systems. Tracing the pathway
connecting Health IT to malpractice claims through latent practitioner-based errors provides a deeper
understanding of how benefits from Health IT are realized. The meaningful use of Health IT has a positive
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effect on the quality of healthcare services by reducing medical errors, resulting in improved patient safety
and also having a direct beneficial impact on practitioners through lowering the risk of malpractice claims.
This study contributes to the literature on the value of Health IT largely and more specifically to the
question of the impact of meaningful use of Certified EHR Technology (CEHRT) on malpractice claims,
medical errors, patient safety, and medical practitioner-based outcomes. Extant literature has provided
inconclusive evidence for the positive impact of Health IT on patient safety and other healthcare outcomes
for several reasons, including sample limitations, inadequate methodology, and a limited focus on Health
IT adoption. Our study significantly overcomes these limitations and examines the effective use and
assimilation effect of Health IT. Prior studies have used several weak proxies of Health IT adoption/use
variables like IT investments, available EHR components, and surveys. The proxy for Health IT in most of
the studies does not measure “use of IT.” Our study belongs to the group of a few recent ones that have
used MU program regulations as a proxy for Health IT use (Lin et al. 2019; Wani and Malhotra 2018). The
MU program attestation records standardized measurement close to the point-of-service (POS), which is a
much better proxy than those used in prior studies, especially those focused on malpractice claims. The MU
attestation is a vastly superior proxy as it directly measures, through a standard process, the “use of IT” in
the practice of medicine by practitioners. Although Lin et al. (2019) and Wani and Malhotra (2018) use the
MU program as a proxy for Health IT usage, they study hospital data to examine hospital outcomes such
as Length-of-Stay (LOS) and overall quality of care. Our study, to the best of our knowledge, is the first
one to examine the impact of meaningful use of Health IT on malpractice claims, looking at the beneficial
impact of Health IT on medical practitioners.
There has been very little work within IS literature in the domain of medical malpractice claims and
Health IT; the existing research mostly concerns malpractice claim premiums (Menon and Kohli 2013;
Ransbotham et al. 2011; Ransbotham and Overby 2010). Our study is one of the first to examine Health IT
impacts on the likelihood of malpractice claims and use robust DiD specifications to draw causal inferences.
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Prior literature in the IS domain has mostly ignored the impact of Health IT on medical practitioners
(Hydari et al. 2019; Lin et al. 2019; Wani and Malhotra 2018) though literature in medicine has focused on
negative effects in terms of effort to adopt, inconvenience, cost of change in clinical practice, etc (Ajami
and Bagheri-Tadi 2013; Boonstra and Broekhuis 2010; Ford et al. 2009). Remarkably, ours is the first study
in the IS domain that shows that Health IT creates a win-win situation as the quality of care improves
through lower practitioner-based medical errors and medical practitioners benefit from a lower risk of
malpractice claims. Moreover, the fear that Health IT may lead to a paper trail increasing the risk of a
malpractice claim is misplaced. Even if the use of Health IT may help in the discovery of medical errors,
the benefit of lowering medical errors themselves outweighs the perceived cost of leaving actional evidence
behind.
The debate related to the effects of Health IT on quality of care has largely been unsettled for a long
time due to inconclusive evidence and mixed results of prior research. We provide strong support to the
positive effects of Health IT realized through meaningful and effective use. One of the reasons for the prior
research being unable to consistently measure the effects of Health IT on quality of care may be because of
its limited focus on the adoption of technology rather than its effective use. Moreover, the unobserved
effects of endogeneity due to self-selection into adoption and use of IT have not been appropriately
addressed in empirical estimations.
Our model-free visualizations reveal a counterintuitive trend in the adoption and use of Health IT by
practitioners. Originally, professionally more diligent and conscientious practitioners were believed to be
proactively selecting into Health IT adoption and meaningful use as compared to their counterparts. Instead,
we find the practitioners who have had more propensity to malpractice claims have been the ones selfselecting into the adoption and meaningful use of Health IT as they seem to see more benefits than the
others.
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Given our unique medical practitioner-level large panel dataset and informed by our model-free
insights and data visualizations, we could determine DiD methodology as the best approach. Perhaps, the
issues of self-selection and endogeneity have not been adequately addressed in prior estimations, leading
to negative effects or mixed results. We believe that our study also provides evidence through the estimation
of the Bivariate Probit model of such issues leading to the estimation of opposite effects if not addressed
carefully.
Our empirical investigation derives its strength from the causal inferences facilitated by the DiD
method. The richness and size of our panel dataset collated from several reliable public data sources have
enabled us to perform several analyses and robustness checks to support our results. Furthermore, the
observation period of our study covers several critical periods of the MU program enactment, and the
recency of data capture has important policy and practice implications.
An important contribution of our study is the use of human evaluation and judgment in conjunction
with the topic modeling approach to improve the interpretability of a large corpus of claim filings. We
provide a method to assimilate and process information from a large number of claim records to extract
themes and inferences. There is valuable information in the malpractice claim records which can help
medical practitioners avoid and reduce medical errors in the future through informed learning. But the
extraction of this information is a tedious and time-consuming process. We provide a novel mechanism to
extract useful information, assisted by human evaluation and judgment to ease the process. This can benefit
medical practitioners and their organizations in particular and the medical fraternity in general in
developing processes and protocols to effectively reduce medical errors.
The findings of our study have important policy implications. The HITECH Act of 2009 was enacted
into legislation to technologically reform healthcare by promoting and expanding the adoption of Health
IT. The MU regulation requires meeting specific measurement criteria reflecting the use of Health IT in
short implementation timelines. Currently, medical practitioners resist Health IT and exhibit skepticism
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about the effectiveness of the strict MU regulation (Ajami and Bagheri-Tadi 2013; Boonstra and Broekhuis
2010) and that may be because they do not perceive any direct benefit but only see the cost in terms of their
time and effort as well as the psychological cost of “changing the clinical practice processes.” Our study
provides evidence for the MU regulation’s benefits to patient outcomes like safety and quality of healthcare
delivery and also to medical practitioners by having lower malpractice claims risk. As HITECH begins to
phase out, the new legislation would come into effect for addressing still unresolved issues of
interoperability, privacy, and security. Any future Health IT policies would need to follow the precedence
of the MU regulation and build upon its positive effects.
The benefits of reducing medical errors and medical malpractice claims arise primarily in the form
of a better quality of care and patient safety. In turn, this also has implications that include patient and
practitioner benefits and costs in terms of litigation, malpractice insurance premiums, indemnity payments,
and defensive medicine. These benefits translate into patient safety and their increased confidence in the
healthcare systems.
Moreover, our study has important practical implications for medical practitioners and healthcare
providers. Our study provides evidence to further support the efficacy of Health IT and its meaningful use
in reducing the risk of malpractice claims; MU not only leads to better patient outcomes in terms of lower
medical errors but also directly benefits medical practitioners. The MU regulation offers benefits and
improves the quality of healthcare delivery not just in hospitals but also in individual office settings.
Healthcare providers should focus on proactively adopting Health IT and its meaningful use rather than
mere adoption. This is so because the true benefits from Health IT are realized only by creating a work
environment conducive to effective Health IT use.
Our study has a few limitations that provide opportunities for future research. Firstly, our dataset is
limited to the State of Florida, whereas combining data from other states in the US would strengthen
findings. Secondly, a larger sample (formed with data from other states) would help explore more
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heterogeneous Health IT effects. Moreover, since our study uses data from only one state, there was no
need to control for variations across states relating to medical liability laws and regulations. A multi-state
dataset would allow us to study the impact of the intersection of liability laws and Health IT on malpractice
claims and also on medical errors. This may help in informing regulators as well as legislative bodies in
charge of formulating laws. Thirdly, we do not have hospital-level data that can help analyze organizationallevel effects, to add to increasing research of meaningful use of Health IT on patient safety and hospital
outcomes. Furthermore, we examined only the main effects of MU when practitioners reached their
respective status. Since Health IT meaningful use can have lagged effects, future research would be able to
enrich our findings by modeling delayed effects.
Future research would be able to investigate the effects of Health IT on the occurrence of malpractice
claims in an organizational setting, such as a hospital. This would help determine heterogeneous effects
based on the size and location of the hospital. Further, a detailed analysis of claim records could help us
identify the most common medical errors addressed by Health IT’s meaningful use in the hospital
environment. Consequently, recent studies on theories of effective use and IT value realization offer
promising direction to extend our study by revealing deeper causal structures of the impact of Health IT
and its effective use.
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CHAPTER TWO:
WHEN TO ACCOUNT FOR THE PATIENT? THE EFFECT OF CLINICAL TREATMENT OF
SOCIAL DETERMINANTS OF HEALTH ON PATIENT HEALTH OUTCOMES

2.1

Abstract
Due to the ever-increasing availability of personalized patient information, it has become vital for us

in healthcare operations management to understand how physicians utilize this information to make their
treatment decisions. One set of information that medical educators have encouraged clinicians to account
for is a patient’s social determinants of health (SDOH). Currently, there have been two assumptions for
these when studying physician decision-making: that patients with similar medical diagnoses are treated
identically, and physician decisions are made rationally according to standard medical practices. We are
told from the personalized medicine literature that acknowledging patient-specific uniqueness is required
for an optimal health outcome. However, in those circumstances where physicians receive no formal
training in patient sensitivity, we posit from that literature that physicians may still intuitively adjust
treatment programs from standard practices for specific medical conditions due to the influence of solely a
patient’s socioeconomic status. It is crucial to understand if these SDOH driven treatment decisions are
taking place, and if they are, to also understand how they affect both a patient’s short-term and long-term
health outcomes. In this work, we look at 1,142 patients admitted for CHF-related issues and whether they
were readmitted within 30 days. We looked to understand whether SDOH factors affect the quality of care
a patient receives during initial treatment visits and whether these variations in quality significantly impact
readmission likelihood. We show that physicians are indeed accounting for socioeconomic factors when
making treatment decisions, but these adjustments do not impact long-term health care outcomes. However,
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SDOH factors still impact readmission likelihood, indicating that physicians are either inappropriately or
inefficiently adjusting their medical decisions when accounting for these patient-specific factors.
2.2

Introduction
Social determinants of health (SDOH) are defined by the World Health Organization as "the

conditions in which people are born, grow, work, live, and age, and the wider set of forces and systems
shaping the conditions of daily life. These forces and systems include economic policies and systems,
development agendas, social norms, social policies, and political systems" (World Health Organization,
2008). SDOH includes tangible and intangible factors encompassing environmental, cultural, political,
socioeconomic, and underlying health factors with a holistic consideration of the patient's well-being. These
factors, in addition to income, social and familial support, education, employment, housing, and gender,
affect the overall health of an individual.
Underprivileged populations with a lower socioeconomic status live and work in more deficient
environments and are, therefore, exposed to higher health risks s leading to worse health outcomes and life
expectancy (Evans et al. 1995). Even though accounting for a patient's SDOH within the clinical treatment
has been touted as an effective strategy to address patient health issues in a holistic framework to achieve
improved health outcomes, there is a lack of empirical evidence supporting this claim.
Despite this, there has recently been an increasing call for medical education and training programs
to utilize the notion of health equity by acknowledging social disparities influencing patient health
outcomes. During rigorous medical training, sensitized practitioners adapt their clinical treatment to
different patients based on varying socioeconomic factors to achieve better health care outcomes (Sharma
et al. 2008). These adaptations then evolve as these practitioners encounter more significant numbers of
patients from diverse backgrounds. This change in medical education and training has led to an increased
emphasis on accounting for SDOH factors in addition to clinical diagnosis when charting the optimal course
of treatment (DeVoe et al., 2016). Therefore, we see healthcare practitioners often adjusting treatment
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plans for several reasons related to SDOH. These may range from certain patient types having noticeably
quicker condition improvement to others who are more likely to have difficulty with appropriate medication
use and post-care treatment compliance. Either way, to make optimal medical treatment choices in these
cases, the practitioner needs to account for a patient's uniqueness to provide the highest quality of care
tailored to the patient's healthcare needs.
Accounting for SDOH increases the likelihood of favorable health outcomes in patients through
personalized treatment plans leading to a surge in adopting a formal SDOH screening as a part of the clinical
care processes (Woolf & Braveman 2011). In the United States, the Centers for Medicare and Medicaid
(CMS) already plans to increase the implementation and adoption of SDOH screening within clinical
practices (Alley et al., 2016).
There is increasing conversation in health care literature encouraging including social determinants
in clinical practice to improve patient health. Though concurrently, there is uncertainty in the medical
community of how perceived social determinants during an initial treatment encounter impact clinical
decisions of health care providers and how that, in turn, affects final health outcomes. This hesitancy is due
to very few hospitals having implemented formal SDOH screening, leaving physicians to rely on their
training and intuition alone to determine a patient's SDOH and to decide how they should utilize this
information (Taylor et al., 2018).
However, when the formal screening process of SDOH is absent in clinical practice, physicians still
can perceive socioeconomic determinants that impact patient health, such as neighborhood safety, the threat
of violence, limited access to transportation, language barriers, and many more (McNeil et al. 2013). A
study across three community health centers uncovered that though most providers can identify relevant
social factors during appointments, they cannot document and account for these factors, in part due to being
strictly limited by the billing codes (Lewis et al. 2016). Thus, even though we know health care providers
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can ascertain the presence of relevant SDOH, it is not clear how physicians account for these factors and
whether they adjust care for all factors or only a selected few.
Therefore, we know that in contrast to a physician's strong ability to perceive how SDOH factors
affect their patients, their ability to deal with these factors effectively is quite diminished due to the
resource-limited environment that the patient may enter post-stay (Garg et al. 2016). Even with careful
screening of social determinants to inform a physician of the adverse conditions beyond the limited scope
of the patient's clinical treatment that may extend and impact patient care, the physician is not well-equipped
to deal effectively and appropriately. Potentially any adaptation the physician makes within the clinical
treatment due to a patient's SDOH may not yield better health outcomes in the long term. This undesired
outcome occurs since reliably addressing health inequity for long-term care would involve connecting
patients with various support resources, such as social services, community development groups, which
might not be available and accessible to all (Alley et al. 2016). Therefore, the lack of post-stay engagement
and resources may mean any initial treatment choices may not yield intended results in the long term. This
situation can be especially acute for chronic care patients, where both clinical visits and continued patient
engagement are required for optimal health outcomes (Northwood et al., 2018).
Thus, in their limited capacity, when the physicians attempt to address SDOH factors within the
clinical treatment, it results in solely the medicalization of SDOH during a clinical decision-making process.
This "clinical treatment" of "social diagnoses" may not necessarily translate into the desired positive health
outcomes and could potentially lead to a depletion of hospital resources dealing with a social problem
ineffectively within the limited clinical treatment scope. This effect motivates us to investigate the efficacy
of including social determinants in clinical decisions when considering patients' long-term health outcomes
and hospital resource utilization.
Through our study, we bridge these gaps by investigating if accounting for a patient's social
determinants impacts the quality of care they receive after controlling other known clinical factors and
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comorbidities. We first investigate how perceiving patients' socioeconomic factors affects the providers'
clinical decisions when a formal SDOH screening is not in place. Secondly, we investigate if this deviation
in the clinical decision process to address a patient's socioeconomic factors leads to improved health
outcomes.
We observed clinical decisions and subsequent health outcomes during chronic care treatments at a
large, academic, urban hospital with no formal SDOH screening. Due to limited documentation on
physician medical decision-making, we utilize the patient's initial length of stay (LOS) as a proxy for how
the physician adapted for SDOH. We do this as LOS is related to the quality of care and is affected by a
complex array of provider decisions associated with clinical and socioeconomic factors (Kossovsky et al.
2002, McDermott and Stock 2007). We then assess the impact of these decisions on the likelihood of 30day patient readmission, an indicator that the initial adaptations were ineffective post-stay. We find
statistically significant evidence that socioeconomic factors impact short-term treatment as physicians
perceive social factors and accommodate clinical treatment accordingly. Surprisingly, we also find that the
impact of including SDOH factors within clinical decisions leads to no significant impact on long-term
patient outcomes.
Our finding has high relevance to health care policy and operations, as informal incorporation of
SDOH into clinical practice decisions without a clear resolution pathway for social treatment has the
potential to lead to unexpected consequences. Dealing with social problems and clinical problems
separately with effective diagnosis and treatment sets may be the critical solution. Therefore, we propose
that physicians and hospitals partner with local organizations and public health institutions to create a
holistic, supportive health care environment, in addition to formally accounting for SDOH in clinical
decision making. These findings also have important policy implications for SDOH screening during
clinical encounters, screening tools within Electronic Health Record (EHR) systems, and improving
hospital resource allocation.
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2.3

Literature Review
In healthcare operations, there is the belief that physicians make their medical decisions and

diagnoses in an unbiased manner based on a patient's medical condition alone. However, if this were the
case, we would, undoubtedly, see a lack of variation in medical outcomes such as post-admittance lengthof-stay (LOS) or 30-day readmission likelihood between patients with similar medical conditions.
However, in practice, we do not see that, despite what the literature may suggest. Thus, our work's
relevance comes from its ability to fit into three different niches of HOM literature: if and how physicians
adjust the process for different patient types to improve outcome quality, how the effect of these adjustments
is measured, and how effective these adjustments are on the patient's long-term health.
2.3.1

Process Adjustment
Presently, when we discuss medical process adjustments, it has primarily focused on the economic

aspects associated with the hospital, such as service time, resource allocation, and capacity, or the riskaverse nature of healthcare providers (Shahian et al., 2017). These studies center around how internal
constraints affect patient outcomes, such as increased workload or decreased interaction with the patient
(KC & Terwiesch 2009, Boyer & Pronovost 2010). This approach fundamentally considers the hospital
environment as the sole driver of process deviation. Therefore, the common belief is that a physician only
alters a patient's treatment plan based upon these internal stressors, not the patients themselves. Though we
often see a relationship between physician performance and hospital management, the literature tends not
to consider that the physician may make treatment choices based on the patient's socioeconomic factors
(Heineke 1995).
There is already a beneficial discussion of the importance of patient engagement and patientphysician collaboration in the literature, but with an emphasis on treatment compliance, not treatment
approach (Cohn 2009). Patient activation - the innate ability to manage and maintain their own health needs
and engagement - has been shown to improve long-term healthcare outcomes and leverage physicians'
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ability to adjust to improve patient outcomes (Queenan et al., 2019). However, this is discussed as solely
a tool that health care providers can utilize only after the initial treatment stage. Our work looks to see if
similar adjustments are made during the initial rounds of treatment. This knowledge would be valuable to
the field to know physicians can make impactful adjustments to patient engagement before discharge.
2.3.2

Impact Measurement
When it comes to how physician decision adjustments are measured, there is a lack of direct

evidence due to previously mentioned documentation limits driving an absence of prior knowledge of
physician choices. However, we know that the use of a patient's length-of-stay (LOS) after treatment is an
appropriate proxy for the impact of both patient care given by the physician and the complexity and severity
of the admittance condition (Song et al. 2015, Berry Jaeker & Tucker 2012, McDermott & Stock 2007).
For our work, this is an important consideration, as it is the primary method by which we can see the impact
of physician deviation behavior based solely on SDOH (Muskat et al., 2017). Furthermore, we know that
hospitals are financially penalized if Medicare and Medicaid patients are kept for an extended period,
dependent on the condition for which they are admitted. Therefore, there must be an additional factor
beyond this, such as SDOH, that would cause the physician to either extend or reduce a patient's stay
(Sheingold et al., 2016).
2.3.3

Adjustment Efficacy
Next, when it comes to the efficacy of these adjustments on the patient's long-term healthcare

outcomes, the literature focuses, as we have mentioned, primarily on post-stay interventions or conditionspecific readmission odds (Oh et al. 2018, Zhang et al. 2016, Billings et al. 2006). Our work looks to
understand the impact of physician choice and deviation behavior in this discussion.
Understandably, patient behavior will majorly affect how patients understand and manage health
care information provided to them by their provider and how capable patients are at maintaining their health
care post-intervention. The literature shows that physicians are aware that different behaviors will have
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different effects on patient outcomes and that they need to account for them during their treatment (Street
2002, Hunt & Arar, 2001). Physicians can be understood to be aware of standard practices and adjust their
behavior accordingly.
If this is the case, we can posit that physicians are subject to reference dependence, an aspect of
prospect theory, where they evaluate their medical decisions relative to a specific "reference patient"
(Neuman & Neuman, 2007). There is little understanding of how physicians develop their reference point
and how closely that adapts to current medical standards of practice. This absence creates difficulty for
how to incorporate this impact on long-term patient outcomes. We need to know how to evaluate this
baseline patient and understand how and why they deviate from this standard behavior pattern.
At present, it is hard to understand when physicians account for patient behavior and whether or
what impacts when they do. However, we know that due to the readmission rate for chronic care patients
remaining high across the United States, there is a process problem. This issue occurs as health care
providers are not accurately identifying either high-risk readmission patients, instead of focusing on more
immediate problems associated with patient admittance and socioeconomic conditions (Feltner et al. 2014).
It comes down to a provider problem, where health care providers need to deliver a form patient-centric
care plan to a patient, but that will also not put them at a higher risk of readmission. Therefore, our work
will also contribute to this problem by delineating which readmission risk factors can be mitigated through
provider treatment choices based on SDOH rather than condition-specific reasons.
2.4

Research Methodology
For this work, we needed to understand how a physician’s decision to account for SDOH could

impact both short-term and long-term patient health outcomes. In our first model, we look at whether the
occurrence of various SDOH significantly affects the variation in a patient’s length of stay (LOS) with
respect to an average patient. Once we make this determination, using our second model, we look at
whether the variations in LOS impact a patient’s 30-day readmission likelihood. Using these results, we
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can see if there is support for our three hypotheses concerning how socioeconomic factors impact physician
decision-making.
2.4.1

Hypothesis Development
To tease apart the different impacts of medical factors (such as admittance condition and

comorbidities) and social determinants of health (such as demographics and socioeconomic factors), we
chose a conceptual model based on the Dual Process Theory. This model provides a universal model of
reasoning and clinical decision-making (Croskerry 2009).
We present our conceptual model in Figure 1. The clinical decision process is not an exact science
and inevitably embraces irreducible uncertainty presented by each case's varied complexity. The Dual
Process Theory breaks down this decision process into two cognitive operations classes to explain human
(a.k.a. physician) reasoning. The analytical cognition class consists of deliberate rule-based cognitive
operations with high reliability and consistent outcomes. On the other hand, the intuitive cognition class
comprises minimal effort cognitive operations vulnerable to errors and biases characterized by fast,
automatic processes with low awareness. However, specific clinical markers and patient characteristics are
expected to trigger the analytical class of cognition operations. Thus, certain socioeconomic factors
perceived directly or indirectly by the physician influence the intuitive class of cognitive operations. We
argue the social determinants of health impact the physician's clinical decision-making process and adds
variability and uncertainty in the clinical decision and related outcomes.
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Figure 2.1: Dual Process Theory for Clinical Decision Making
This impact becomes significant when we consider the forms of training that physicians receive in
the area of SDOH (Taylor et al. 2016, Woolf & Braveman, 2011). Due to the lack of hospital protocols on
the optimal way for physicians to account for SDOH, health care providers are left to rely on their intuition
and experience to adjust their treatments from their condition-specific reference patient. This lack of support
makes it difficult for physicians to directly quantity how they adjust their treatment plans, as, managerially,
intuition is considered "charged judgments that arise through rapid, nonconscious, and holistic associations"
(Dane & Pratt 2007).
Our work utilizes this conceptual model by isolating which, if any, SDOH significantly affects
treatment variability. Suppose the patients' quality of care is only significantly affected by the patients'
medical conditions. In that case, we can state that clinical factors only drive both a physician's analytical
and intuitive cognition. This interpretation does not imply that physicians do not deviate their treatment
behaviors based on social factors; it just means that these deviations do not significantly impact immediate
patient care or long-term health care outcomes. This outcome in itself would be a consequence of value to
medical educators and those involved in the design of healthcare processes.
Therefore, based on our conceptual model, we have determined our three hypotheses:
Hypothesis 1: Patient's socioeconomic factors are associated with the absolute deviations in a patient's
length of stay.
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Hypothesis 2A: Absolute deviation in a patient's length of stay is associated with worse patient outcomes
in the form of a higher risk of readmission.
Hypothesis 2B: A patient's socioeconomic factors are associated with worse patient outcomes, such as a
higher risk of readmission.
2.4.2

Data Description
For this work, we collected data on 1142 chronic-care Medicare and Medicaid patients from a large,

academic, urban teaching hospital, who were admitted for CHF-related issues (Congestive Heart Failure)
between August 2016 and October 2017, see in Table 2.1. Also, we received data on whether or not patients
were readmitted within 30-days of discharge. As our work investigates the effect of the physician treatment
deviation on patient health care outcomes based on their SDOH, we identified patients' length of stay (LOS)
as a proxy for the quality of care that the patient receives during their initial admission. LOS is a significant
factor in determining the quality of the treatment received by CHF patients, particularly their readiness for
discharge (Kossovsky et al. 2002).
LOS is calibrated by physician decisions that are, in turn, influenced by not only the patient's
medical condition and comorbidities but also their socio-economic conditions. Therefore, to isolate the
impact of SDOH on the physician's decision behavior, we identify within our dataset four major conceptual
contributors to the variation in patient LOS and 30-day readmission risk, which are as follows:
1. Patient's deviation from their Geometric mean LOS (GMLOS). GMLOS constitutes a guideline for
standardized care based on Medicare severity diagnosis-related groups (MS-DRGs) by the Centers
for Medicare and Medicaid Services (CMS), used for financial reimbursements. It is a standardized
reference point for studying deviations in LOS (Oh et al., 2018). These deviations indicate that the
physician is making treatment decisions for the patient that differ from those of a standard reference
patient.
To predict readmission likelihood, we decided to use the patient's absolute GMLOS as we are
investigating if the physician was varying their treatment plan based on SDOH or not. We removed
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from our data set any with a LOS of over 17 days. These patients were considered outliers, as they
had the stays extended due to unexpected complications not associated with the initial admission
condition or variations in treatment. This decision also aligns with CMS cost guidelines associated
with length of stay, which financially disincentivizes physicians to increase a patient's time in the
hospital unnecessarily (Centers for Medicare & Medicaid Services 2013).
2. Patient's social determinants of health including age, gender, ethnicity (white or non-white),
employment status, and spoken language (English or non-English).
3. Patient's medical admittance condition (MS-DRG code) and the presence of comorbidities linked
to socioeconomic statuses, such as drug-addiction, obesity, and having an immuno-compromised
condition (ex. HIV, Hepatitis) (Tuzun et al. 2015). We chose not to include comorbidities
commonly associated with CHF, such as kidney failure, respiratory failure, or Type-2 diabetes, as
they were present in the majority of patients.
4. The patient's discharge destination indicates the type of care facility to which a patient is
discharged. It is indicative of the post-acute care coordination available to the patient (McGarry et
al., 2016). Patient discharge destinations include home care, a care facility (either short-term,
intermediate-term, or long-term), and if they chose to discontinue care - when patients leave against
medical advice. Even though the physician would not be aware of this information when making
their treatment decisions, the destination contributes to condition non-related LOS as patients wait
for beds to become available at their discharge facility (Picone et al. 2003).
Table 2.1: Summary Statistics of CHF Patient Dataset
Mean

S.D.

Min

Max

LOS (in days)

6.164

3.854

1

17

GM-LOS (in days)

4.268

0.968

1.3

14

Deviations LOS (in days)

1.928

3.859

-5

13.4
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Table 2.1 (Continued)
Gender:

Discharge Destination:

Male

504 (52.72%)

Home

795 (83.16%)

Female

452 (47.28%)

Facility

119 (12.45%)

Discontinued-Care

42 (4.39%)

Ethnicity:
White

305 (31.90%)

Comorbidities:

Non-White

651 (68.10%)

Drug Addiction

350 (36.61%)

Obesity

222 (23.22%)

Language:
English

775 (81.07%)

Immuno-Compromised

104 (10.88%)

Non-English

181 (18.93%)

Readmissions:

240 (25.10%)

Age Groups:

MS-DRG Groups:

25 – 44 years

64 (6.69%)

219 - 228 (Cardiac Valve)

16 (1.67%)

45 – 64 years

362 (37.87%)

306 (32.01%)

65 – 74 years

247 (25.84%)

75 years and over

283 (29.60%)

280 - 285 (Acute Myocardial
Inf.)
286 - 287 (Circulatory
Disorder)
291 - 293 (Heart Failure)

Full-time

46 (4.81%)

270 - 279 (Major Cardiac
Procedure)
242 - 252 (Pacemaker)

Part-time

21 (2.20%)

Disabled

232 (24.27%)

Retired

403 (42.15%)

Unemployed

241 (25.2%)

Employment Status:

2.4.3

255 - 266 (Device
Replacement)
981 - 987 (OR Procedure)

79 (8.26%)
506 (52.93%)
7 (0.73%)
21 (2.20%)
12 (1.26%)
9 (0.89%)

Model Description
Our dataset includes patient admission characteristics such as the length of stay (LOS), initial

medical admittance condition, and comorbidities. Since each patient record is associated with the Medicare
Severity Diagnosis Related Group (MS-DRG) code, we measure the absolute deviation in length of stay
from GMLOS by first matching the patient's MS-DRG code to the corresponding MS-DRG specific
GMLOS as published by the CMS. We then calculate the absolute value of the difference between the
reported LOS and GMLOS to construct our response variable. We consider any absolute deviations less
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than one day in LOS from GMLOS as no deviation for the ease of interpretability of results. We model the
absolute deviation of LOS from GMLOS as given below:

absdeviationLOSi  LOSi  GMLOSi   0  1Di   2Ci   3 Ai   4 SEi  1i

(1)

where i indexes the patient. Di represents patient-specific demographic control variables such as gender
and age, Ci represents clinical factors like drug-addiction, obesity, and immuno-compromise Ai represents
administrative factors like patient's discharge destination, SEi represents patient-specific socioeconomic
factors like ethnicity, employment status, spoken-language, and interaction between ethnicity and
employment variables, and i represents the error term. The dependent variable, absdeviationLOSi ,
represents the absolute deviation in LOS from the standardized measures of GMLOS. The response variable
results from the physician decision-making process as the physician performs diagnosis using a holistic
approach considering clinical and socioeconomic factors of the patient into the treatment plan. We have
included discharge destination as an administrative factor as prior studies have reported the effect of
discharge destination on the readmission odds through an effect on LOS (McGarry et al. 2016).
Prior readmission literature has extensively used logit regression models to estimate the
readmission probability of patients modeling a dichotomous outcome variable based on whether the patient
was readmitted within 30 days of discharge (Bardhan et al. 2015, Oh et al. 2018). We also adopt a logit
regression model to estimate the probability of readmissions, pi , in our second model to evaluate the effects
of socioeconomic factors and absolute deviations of LOS from GMLOS on readmission odds.

 p
ln  i
 1  pi


2
  ln  readmissioni    0  1absdeviationLOSi   2 Di   3Ci   4 Ai   5 SEi  i


(2)

where i indexes the patient. absdeviationLOSi represents the absolute deviation of LOS from GMLOS,

Di represents patient-specific demographic control variables, Ci represents clinical factors or
comorbidities, Ai represents administrative factors, and SEi represents patient-specific socioeconomic

79

factors. The dependent variable, readmissioni , represents the incidence of readmission, with a value of 1
if the patient is readmitted within 30-days of last discharge and 0 otherwise. To estimate the statistical
association between the patients' socioeconomic factors and their readmission risk, we employ a widely
used cox proportional hazards model (Catena et al. 2020, Guo & Shenyang 2010). Our time variable is the
number of days to readmission, which is censored at 30 days. The model is formulated as given below,
where the variables have the same representations as provided earlier:

hi  t   h0  t  exp 1absdeviationLOSi   2 Di   3Ci   4 Ai   5 SEi 

(3)

The above model equation (3), h0  t  represents readmission risk hazards faced by the patient i after t
days post-discharge while h0  t  represents baseline readmission risk hazard faced by all patients
concerning the readmission risk. The proportional hazards assumption, in our study, translates to the ratio
of hazards related to readmission risk for two patients being constant over time. We test this proportional
hazard assumption for our model based on the generalizations by Grambsch and Therneau (1994). They
suggested that the tests for proportional hazards are essentially the tests of non-zero slope in a generalized
linear regression of the scaled Schoenfeld (1982) residuals on functions of time (Cleves et al. 2010).
2.5

Results
We report the coefficients obtained from the first model's linear regression as specified by Equation

(1) in Table 2. Model 1(a) does not include administrative and socioeconomic factors, Model 1(b) includes
the administrative factor while ignoring the effect of socioeconomic (SE) factors, and Model 1(c) reports
all measures of Equation (1).
Table 2.2: Linear Regression Estimation of Absolute Deviation LOS
VARIABLES
Age Group: (Control - 25-44 y)
(45-64 y)
(65-74 y)

Absolute Deviations LOS = |GMLOS - LOS|
Model 1(a)
Model 1(b)
Model 1(c)
0.260
(0.387)
0.0284
(0.399)

80

0.198
(0.387)
-0.0915
(0.404)

0.0506
(0.392)
-0.128
(0.439)

Table 2.2 (Continued)
(75+ y)
Gender: (Control – Female)
Male

-0.0674
(0.398)

-0.307
(0.405)

-0.182
(0.475)

-0.327*
(0.195)

-0.276
(0.192)

-0.296
(0.195)

-0.469**
(0.183)
0.302
(0.244)
0.147
(0.299)

-0.531***
(0.183)
0.167
(0.246)
0.110
(0.299)

-0.00101
(0.510)
1.276***
(0.321)

-0.109
(0.518)
1.252***
(0.321)

Clinical Factors
Drug Addiction

-0.451**
(0.185)
Obesity
0.270
(0.247)
Immuno-Compromised
0.104
(0.296)
Administrative Factor: (Control - Home)
Discontinued-Care
Facility
Socioeconomic Factors
Ethnicity: (Control - White)
Non-White

-1.137
(0.792)

Language: (Control - Non-English)
English

-0.252
(0.229)

Employment: (Control - Full-time)
Part-time

-2.623**
(1.049)
0.468
(0.802)
-0.884
(0.732)
-0.638
(0.751)

Disabled
Retired
Unemployed
Ethnicity # Employment (Control - White # Full-time)
Non-White # Part-time

2.587*
(1.326)
Non-White # Disabled
0.177
(0.929)
Non-White # Retired
1.319
(0.834)
Non-White # Unemployed
1.347
(0.892)
Constant
3.445***
3.380***
4.121***
(0.410)
(0.410)
(0.775)
Observations
956
956
943
R-squared
0.012
0.033
0.051
Note: Robust standard errors in parentheses *** p<0.01, ** p<0.05, * p<0.1

Our results indicate significant absolute deviations of LOS from GMLOS due to socioeconomic
factors when clinical factors were controlled. The absolute deviation LOS registers a statistically significant
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increase of about 1.25 days when the discharge destination is a facility rather than home. As compared to
patients of white ethnicity, non-white ethnicities indicate lower absolute deviation LOS. Although not
statistically significant in our study sample, this suggests that the treatment received by non-white
ethnicities has less variation from the standard patient. There is a statistically significant decline in the
absolute deviation LOS in the case of patients suffering from drug addiction by almost half a day compared
to their counterparts without any substance abuse history. This could be due to physicians not wishing to
adjust their treatment plans due to a known history of low treatment compliance in these patients (Pristach
& Smith 1990). Also, we observe that part-time employment status patients have absolute deviation LOS
less than their full-time employed counterparts by almost 2.6 days. This result may be because the time
away from work is more critical to their earnings than their full-time employed counterparts.
These results support Hypothesis 1, that socioeconomic factors are associated with absolute
deviations in LOS from GMLOS. Therefore, beyond the administrative and clinical factors, socioeconomic
factors result in absolute deviations in LOS, which can be mostly attributed to the patient's economic status.
We report our results for the logit regression specified by Equation (2) in Table 3. Model 2(a) does not
include administrative and socioeconomic factors, Model 2(b) includes administrative factors while ignores
the effect of socioeconomic (SE) factors, and Model 2(c) reports all parametric estimates of Equation (2).
Table 2.3: Logit Regression Estimation of Readmission Risk (Odds-Ratios)

VARIABLES
Absolute Deviation LOS
Age Group: (Control - 25-44 y)
(45-64 y)
(65-74 y)
(75+ y)
Gender: (Control – Female)
Male
Clinical Factors
Drug Addiction

Overall Estimation
Readmission Risk (Odds Ratios)
Model 2(a)
Model 2(b)
Model 2(c)
1.030
1.031
1.028
(0.0268)
(0.0271)
(0.0277)

LateDischarge
Model 2(d)
1.035
(0.0308)

EarlyDischarge
Model 2(e)
0.890
(0.0871)

1.054
(0.319)
0.668
(0.216)
0.793
(0.255)

1.088
(0.333)
0.713
(0.235)
0.859
(0.284)

1.058
(0.334)
0.523*
(0.192)
0.544
(0.224)

0.931
(0.415)
0.593
(0.294)
0.644
(0.353)

0.926
(0.398)
0.307**
(0.171)
0.271**
(0.171)

1.031
(0.163)

1.010
(0.161)

1.040
(0.169)

0.987
(0.205)

1.069
(0.272)

0.827
(0.135)

0.822
(0.134)

0.782
(0.131)

0.832
(0.181)

0.631*
(0.159)
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Table 2.3 (Continued)
Obesity
Immuno-Compromised

1.163
(0.211)
1.274
(0.297)

Administrative Factor: (Control - Home)
Discontinued-Care
Facility

1.151
(0.209)
1.209
(0.286)

1.109
(0.208)
1.162
(0.280)

1.011
(0.247)
1.404
(0.426)

1.259
(0.372)
1.210
(0.436)

1.831*
(0.602)
0.971
(0.236)

1.519
(0.502)
0.920
(0.225)

1.750
(0.881)
0.801
(0.229)

1.271
(0.541)
1.321
(0.596)

0.671**
(0.111)

0.783
(0.163)

0.564**
(0.151)

0.816
(0.176)

0.903
(0.249)

0.648
(0.221)

2.488
(1.900)
5.295***
(2.946)
5.898***
(3.510)
3.432**
(1.895)
0.125***
(0.0799)
943
-512

1.535
(1.493)
6.161***
(3.963)
4.528**
(3.099)
3.135*
(2.028)
0.121***
(0.0939)
596
-325

5.191
(6.820)
6.555*
(7.349)
15.28**
(18.54)
5.976
(6.590)
0.150
(0.177)
403
-213

Socioeconomic Factors
Ethnicity: (Control - White)
Non-White
Language: (Control - Non-English)
English
Employment: (Control - Full-time)
Part-time
Disabled
Retired
Unemployed
Constant
Observations
Log-Likelihood

0.346***
(0.115)
956
-533

0.326***
(0.110)
956
-531

Note: Robust standard errors in parentheses *** p<0.01, ** p<0.05, * p<0.1

We observe no statistically significant effect of the absolute deviation of LOS from GMLOS on
the readmission odds once we control for the patients' administrative, clinical, and socioeconomic factors.
The age group of 65 to 74 years observes a readmission risk of around 48% less than the patients aged 25
to 44. The readmission odds are around 33% lower for patients of non-white ethnicity as compared to
whites. A careful analysis reveals that ethnicity's social factors may not be as significant in changing the
readmission odds than the economic factors of employment status. We observe the readmission odds for a
disabled individual are five times higher, and those of a retired individual are almost six times higher than
those of a full-time employed patient. Meanwhile, the readmission odds are more than three times higher
for unemployed compared to full-time employed patients. This effect can be explained by the quality of
aftercare, insurance coverage, and financial instability.
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These results strengthen the inference that socioeconomic factors play a significant role in
readmission risk while the absolute deviation of LOS from GMLOS does not significantly affect
readmission odds. While we cannot support Hypothesis 2A, a patient's absolute deviation in length of stay
is associated with a higher risk of readmission; empirically, we find statistical confirmation for our
Hypothesis 2B that the socioeconomic factors are associated with higher readmission risk. The combined
result of these two hypothesis tests suggests that the deviation from standard GMLOS does not help reduce
the readmission risks as socioeconomic factors are associated with higher risks when administrative,
clinical, and demographic factors have been controlled.
We further analyze the readmission risk based on the early or late discharge of a patient. We classify
patients in our study into three groups based on the magnitude of their absolute deviation of LOS from
GMLOS. The "Early-Discharge" group consists of patients who have LOS less than GMLOS by more than
one day. Similarly, the "Late-Discharge" group consists of patients who have LOS more than GMLOS by
more than one day. The "On Time-Discharge" group consists of patients with the actual LOS within a 1day range of the GMLOS. We first compare the readmission risk of the "Early-Discharge" group with the
"On Time-Discharge" control group and then compare the readmission risk of the "Late-Discharge" group
with the "On Time-Discharge" group. We report the odds-ratios from these two logit regressions as Model
2(d) for the "Late-Discharge" group and Model 2(e) for the "Early-Discharge" group in Table 3.
In the "Late-Discharge" group, we observe that the employment status statistically impacts the
readmission risk while the effect of ethnicity is no longer statistically significant. Disabled patients
experience six times higher readmission risk odds, retired patients experience almost five times, and
unemployed patients experience three times compared to their respective counterparts. Interestingly,
ethnicity shows a significant effect on the readmission risk odds in the "Early-Discharge" group, with nonwhites having about 44% lower odds than their white counterparts. Moreover, 65 years old and over
experience around 30% lower readmission risk odds than the age group of 25-44 years old in the "EarlyDischarge" group. Also, retired patients in this group experienced a significantly high readmission risk of
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about fifteen times that of the full-time employed individuals. This result shows an early discharge affects
socioeconomically challenged patients more than their peers.
2.5.1

Validation

We performed a Cox proportional hazards survival analysis using the number of days post-discharge to
readmission as a time variable and present hazard ratios and coefficient estimates in Table 2.4. The
proportional hazards assumption was tested using Schoenfeld (1982) residuals. The p-values obtained for
the global analysis and individual covariates showed no statistical significance to reject the null hypothesis
of proportional hazards. Thereby assuring the proportionality assumption has not been violated in our
analysis. This outcome, however, can also be graphically observed in comparative hazard plots presented
in Figure 2.2.
Table 2.4: Cox Proportional-Hazards Regression Estimation Results
VARIABLES
Absolute Deviation LOS
Age Group: (Control - 25-44 y)
(45-64 y)

Hazard Ratios
Model 3(a)
Model 3(b)
1.0299
1.0254
(0.0237)
(0.0238)

Coefficient Estimates
Model 3(c)
Model 3(d)
0.0295
0.0254
(0.0231)
(0.0232)

1.0959
(0.284)
0.745
(0.209)
0.903
(0.257)

1.0620
(0.284)
0.591*
(0.184)
0.639
(0.226)

0.0916
(0.260)
-0.295
(0.281)
-0.102
(0.284)

0.0602
(0.267)
-0.526*
(0.310)
-0.448
(0.353)

1.0292
(0.141)

1.0440
(0.143)

0.0288
(0.137)

0.0430
(0.137)

0.847
(0.120)
Obesity
1.114
(0.169)
Immuno-Compromised
1.160
(0.299)
Administrative Factor: (Control - Home)
Discontinued-Care
1.762**
(0.477)
Facility
0.9508
(0.200)

0.816
(0.118)
1.0787
(0.166)
1.1048
(0.220)

-0.166
(0.142)
0.108
(0.152)
0.149
(0.198)

-0.204
(0.144)
0.0757
(0.154)
0.0997
(0.199)

1.516
(0.407)
0.9096
(0.193)

0.566**
(0.271)
-0.0504
(0.211)

0.416
(0.269)
-0.0947
(0.213)

(65-74 y)
(75+ y)
Gender: (Control – Female)
Male
Clinical Factors
Drug Addiction
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Table 2.4 (Continued)
Socioeconomic Factors
Ethnicity: (Control - White)
Non-White
Language: (Control - Non-English)
English
Employment: (Control - Full-time)
Part-time

0.700**
(0.097)

-0.356**
(0.138)

0.834
(0.158)

-0.181
(0.189)

2.384
(1.667)
Disabled
4.410***
(2.268)
Retired
4.689***
(2.542)
Unemployed
3.225**
(1.665)
Observations
956
943
956
Log-Likelihood
-1607
-1578
-1607
Note: Robust standard errors in parentheses *** p<0.01, ** p<0.05, * p<0.1

0.869
(0.699)
1.484***
(0.514)
1.545***
(0.542)
1.171**
(0.516)
943
-1578

These results indicate a statistically significant effect of socioeconomic factors on the readmission
risk hazards. Model 3(a) shows discontinued care increases readmission hazard by about 76% when we do
not control the socioeconomic factors. This effect disappears when we include the socioeconomic factors
in Model 3(b). We find patients of a non-white ethnicity have about 30% lower readmission hazard than
white individuals. Also, disabled and retired individuals have around four times the higher hazard of
readmission than full-time employed patients, while unemployed patients have about three times higher
readmission risk hazard. Again, this result verified our Hypothesis 2B, that socioeconomic factors influence
readmission risk in patients after accounting for other clinical, administrative, and demographic factors
have. The plots in Figure 2.2 provide a visual interpretation of these results with comparisons within
covariate levels.
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Figure 2.2: Comparative hazards for readmission risk based on (a) age-group, (b) gender, (c)
comorbidities, (d) discharge destination, (e) employment, and (f) ethnicity and language.
2.6

Discussion
Our work contributes to the literature concerning how to account for SDOH when making clinical

decisions, such as the assignment of treatment plans. Our work's motivation was to understand if physicians
indeed did account for socioeconomic factors when making medical decisions for a patient, as we
understood from the literature that this was supposed to have positive health outcomes for patients,
including lower readmission likelihoods (Hoyler et al., 2020).
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However, our data illuminated another aspect of this process. We show that though physicians
account for SDOH during the initial treatment phase, this does not translate into improved healthcare
outcomes. Patient readmission likelihood is not directly affected by treatment variations due to the patient's
initial visit.
One question posited in the literature discusses how we know physicians endeavor to account for
SDOH during the clinical process. We do not know if these deviations in treatment plans are significant or
effective. From our data, we see that the social determinants of health that significantly affect treatment
variation are employment status, history of drug addiction, and discharge destination. Therefore, if a
physician were to account for other factors, these choices did not significantly impact the quality and type
of care a patient received, as seen through our LOS proxy.
Apart from demonstrating that a physician's clinical decisions are significantly affected by SDOH,
the contribution from our work is how we show that these choices do not have a significant impact on
readmission likelihood. Conversely, it is the socio-economic factors themselves – specifically ethnicity
and employment status – that affect whether or not a patient is likely to be readmitted within 30 days of
their initial visit.
Our model also demonstrated that these significant socioeconomic factors differed depending on
whether the patient was discharged "earlier" than average or "later". This result is striking as if a patient is
kept in the healthcare environment longer, the only significant factor for readmission is employment status.
Whereas if a patient was discharged early, thus receiving less in-hospital care, then ethnicity, age, and
history of substance abuse, in addition to employment status, significantly drove whether or not the patient
was likely to be readmitted.
It is essential that for this work to contribute to healthcare operations literature, we understand the
implications of these results for both researchers and clinicians. We also acknowledge the study's limitations
that will suggest the future work that needs to be done in this domain.
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2.6.1

Implications for Operations Management Researchers
A fundamental contribution of this work for researchers is that we need to reconsider how we

analyze the idea of "clinical treatment" of "social diagnoses." In the literature, we focus primarily on how
physicians' in-hospital adaptations impact a patient's long-term health outcomes, hence why LOS is used
as a proxy for quality of care. We see in this work that these deviations from standard treatment patterns
do not significantly affect readmission likelihood. However, we cannot conclude whether accounting for
SDOH does not affect health outcomes as the standard treatment model is appropriate for all patients with
the same medical condition, or whether the way physicians account for SDOH is suboptimal or
inappropriate.
This inability to decipher precisely why accounting for SDOH does not affect patient outcome
contributes to how we consider Dual Process Theory. When it comes to how physicians determine their
treatment choices based on SDOH, we need to assert whether the issue is one of analytical cognition (if
how physicians are trained to account for SDOH is inappropriate) or a one of intuitive cognition (whether
the physician has innate biases affecting their decisions). Our work has shown that in the absence of
sensitivity training, a physician's intuitive cognition cannot adequately account for SDOH in a manner that
has a positive health outcome. This assertion tells us that physicians' innate biases are not enough to affect
the likelihood of readmission but that we need to study how different training approaches allow analytical
cognition to override these intuitive approaches.
Alternatively, this work demonstrates that counter to currently held beliefs in operations
management literature, not all healthcare processes need to be personalized. A standard care approach not
altered by SDOH adjustments may provide a higher quality of care for patients (Edwards et al., 2017). In
our case, not accounting for SDOH would have allowed patients to spend almost three additional days in a
hospital setting, which may have improved the care they received.
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As healthcare operations researchers, it is also crucial for us to consider healthcare treatments to
extend beyond the hospital setting. Our work shows that the physician's SDOH-related choices in the
hospital setting did not have a significant effect on readmission likelihood. However, we saw that these
same SDOH factors were the significant drivers of readmission likelihood. Therefore, we can infer that
there is a part of the perioperative process after the patient has left the hospital that drives adverse health
outcomes directly related to SDOH.
In healthcare operations literature, it has repeatedly been demonstrated that the utilization of postcare telemedicine has improved patient engagement, patient health outcomes, and lowered readmission
rates (Queenan et al., 2019; Williams et al., 2017). Our work has indicated the importance of studying this
post-care patient experience to see if the physician's treatment choices were impactful. If indeed how the
physician-altered treatment affected how the patient engaged with their health once they left the hospital,
then a moderated-mediation model could be utilized to understand if SDOH treatment alterations have an
indirect effect on readmission likelihood rather than the expected direct effect.

Figure 2.3: Moderated-Mediation Model accounting for Patient Post-Care Engagement
2.6.2

Implications for Clinicians and Medical Educators
Our work has implications for researchers regarding how we can consider the impact of treatment

decisions within the healthcare process and how different cognition forms can strengthen how physicians
approach these treatment alterations. However, our work also has profound implications for clinicians and
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hospital administrations, both in how they should account for SDOH and how they should deal with any
process inefficiencies that may arise due to these choices.
If we look at the reasons our model indicates are significant drivers of LOS deviation during initial
treatment, we can understand that there may be inefficiencies driving these deviations rather than the
physician simply accounting for SDOH. One of the significant factors for an increase in the length of stay
is whether or not a patient was discharged to an additional facility instead of their home – with an increase
of approximately 1.3 days being reported.
We can assert that this delay is not due to treatment decisions but due to a lack of vacancies in the
respective care facilities. When a patient cannot be promptly transferred, they remain in the hospital until
such a time as they can be safely discharged. This inefficiency can add up to 15 days to a patient's LOS,
take beds away from new patients who need them, and lower hospital capacity, thus increasing cost for the
hospital (Harrington et al., 2005; Kim et al., 1999; Li et al., 2002).
If the hospital were to improve relations with care facilities, they could reduce up 151 days' worth
of bed capacity for these patients alone. The converse here is an essential tool for hospital administrations.
We know keeping a patient longer than needed increases hospital inefficiency, but what we also see in our
model is that patients discharged later than average have a 20% lower likelihood of being readmitted within
30-days, independent of SDOH factors. We know that when a patient is kept in the hospital longer,
socioeconomic factors are much less significant drivers of readmission.
This finding is of interest to hospital clinicians. In the literature, it is believed that even though the
increased length of stay is associated with a better quality of care, it is not significantly related to lowered
readmission likelihoods (Damrauer et al., 2015). Furthermore, the literature states that socioeconomic
deprivation is the primary driver of readmissions after medical condition severity is accounted for
(Cournane et al., 2015). This understanding could be further indication that the length of stay for the patient,
though not directly affecting the likelihood a patient will be readmitted, maybe having an indirect effect on
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the patient's ability to manage and maintain their health once they have left the hospital facility. It is known
that when patients have increased communication and interaction with their healthcare providers, that their
engagement increases (Flickinger et al., 2013). Therefore, this inefficient increased length of stay could
indirectly affect long-term health outcomes and further study.
For clinicians and hospital administrators, the differences in how SDOH impacts readmission
likelihood based upon "early" or "late" discharge could also be related to patient engagement and the
importance of additional communication between healthcare providers and patients. The importance of the
information given to patients when they are discharged is known to affect both patient engagement and
patient health outcomes (Tobiano et al., 2019). Therefore, if administrators wish to encourage reduced
lengths of stay for patients, to receive the impact of additional benefits of added communication, a
personalized approach to discharge information specifically targeting the significant SDOH factors
(ethnicity, age, employment status, and substance abuse history) could be beneficial.
This benefit could extend to adjusting care decisions based on a social determinant of health that
affected both variations in the length of stay and likelihood of 30-day readmission – employment status.
Our model demonstrated how patients who are unemployed, disabled, retired, and part-time workers are
significantly disadvantaged when it comes to their likelihood of readmission. Hospital administrators and
clinicians need to understand this when making discharge and post-care treatment decisions.
It is known that when it comes to how community factors affect readmission rates, that the strongest
of these factors is "access to care" (Herrin et al., 2015). Income, and by association employment status, is
the significant indicator of the quality of care a patient can access when the location is taken into account.
Therefore, if administrators wish to account for SDOH drivers of readmission, a way to start would be
making sure those with lower access to care post-hospital (which accounts for greater than 95% of our
patient population) have better access to information and resources that could prevent future readmissions.
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Lastly, medical educators must address the importance of training physicians to account for SDOH
during treatment phases. In our work, we were unable to separate if any training physicians received in
inpatient socioeconomic sensitivity drove how they altered choices based on SDOH factors or intuition
alone. Therefore, we must go beyond the anecdotal – and study and implement different training
methodologies to aid physicians in making optimal treatment choices to improve long-term health
outcomes. This improvement is essential because, in the operations literature presently, we have only
studied how sensitivity training affects initial treatment interactions.

We have seen that increased

sensitivity to socioeconomic factors improves patient satisfaction and quality of care received; however,
there has been no evidence on how this affects long-term health outcomes before our work. Though
adapting for SDOH affects initial treatment quality of care, we do not see these adaptations leading to
reduced readmission rates – even though we see socioeconomic factors themselves driving readmissions.
Therefore, clinicians and medical educators must develop and study patient sensitivity training programs
with short-term and long-term benefits.
2.6.3

Limitations
Our work provides insight into how physicians account for social determinants of health and how

their current methods of adjusting treatment plans seem to have no direct effect on long-term patient health
outcomes. However, due to the nature of healthcare operations research, where our data is directly
concerned with patient-specific information, future work needs to address some limitations.
In our work, we use an understood proxy for quality of care – patient length of stay – to gain insight
into physician treatment adjustments. Our model indicates there is a significant relationship between SDOH
and LOS variations. However, without interviews with the attending physicians, we can only surmise that
these variations are consciously due to socioeconomic factors rather than an unconscious bias or some other
factor. Future work should look at this relationship concurrently with additional physician and patientspecific information.
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Additional information around physician decision-making could come from specific treatment
decisions for each patient, knowledge of the physician’s patient sensitivity training background or SOAP
(subjective, objective, assessment, plan) notes from a patient’s chart. If this information were available, it
would indicate whether the physician’s cognition of SDOH was analytical or intuitive and the efficacy of
different forms of sensitivity training on short-term patient outcomes.
Alternatively, additional patient-specific data concerning engagement and satisfaction would allow
researchers to understand the potential indirect effect of initial treatment variations on long-term healthcare
outcomes. This data is available from CMS, but in order to collect patient-level data, interviews would need
to be conducted at the time of initial treatment.
In our work, we also learn that though there is no direct effect of physician decision-making due to
socioeconomic factors on long-term health outcomes, the SDOH factors are significantly related. This
assertion implies that the decisions made during the initial treatment phase may occur in the post-care phase.
To understand this effect, researchers need to follow patients for the 30 days post-initial treatment. We
only knew if the patient were readmitted in our data without any information on the pre-readmission
engagement or treatment compliance. As we begin to view healthcare holistically, we need to address this
limitation with a longitudinal study. A study of this form would allow us to understand the indirect effect
of treatment decisions on long-term patient health outcomes and also garner insight concerning the impact
of discharge information and follow-up communication on patient engagement for those with different
SDOH factors (Vest & Ben-Assuli, 2019; Thomas-Henkel & Schulman, 2017; White-Williams et al.,
2020).
2.7

Conclusion
Our work looked into whether physicians adjust their treatment decisions for chronic-care patients

based upon socioeconomic factors known as social determinants of health. We wished to explore whether
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these adjustments occurred and if they had an impact, either positive or negative, on short-term and longterm patient health outcomes.
This study demonstrated that physicians account for socioeconomic factors during the initial
treatment phase – specifically employment status, discharge location, and substance abuse history. Also,
we observed that though accounting for SDOH factors significantly affects variations in treatment; these
variations do not affect long-term patient health outcomes. However, our model shows that though
physician decisions do not directly impact patient readmission likelihood, a patient’s socioeconomic factors
are significant predictors – especially ethnicity, employment status, age, and substance abuse history. This
relationship indicates that there is potentially an indirect effect on patient engagement due to how physicians
adjust their treatment plans.
Our work informs healthcare operations researchers that to understand the process impact of
deviations in physician decision-making, we need to look at the patient-provider relationship post-care and
while admitted in order to understand these indirect effects on readmission likelihood. Our work will also
help medical educators consider the importance of testing the efficacy of different patient sensitivity
training formats, as we have demonstrated that accounting for SDOH impacts patient short-term health
outcomes, just not in an optimal manner. Our findings also indicate to hospital administrations the
importance of patient-provider communication before pre- and post-discharge due to its effect on patient
engagement and 30-day readmission rates.
2.8
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CHAPTER THREE:
ROLE OF HEALTH IT IN LONG-TERM POST-ACUTE CARE FACILITIES
3.1

Abstract
Although the impact of Health IT and Electronic Health Records (EHRs) adoption and use has been

investigated in acute-care settings, there is a lack of understanding about the application and efficacy of
Health IT in the long-term and post-acute care (LTPAC) facilities. How do Health IT adoption and use
affect the rapidly evolving LTPAC sector of the U.S. healthcare economy? This study investigates the role
of the Health IT on LTPAC facilities by adopting a configurational perspective towards organized
complexity of LTPAC transitions of care business strategy. We examine data obtained from an organization
that operates more than 200 long-term and post-acute care (LTPAC) facilities in multiple states. Our
research investigates parsimonious configurations for the high qualitative performance of LTPAC facilities
with Health IT characterized by organizational complexity.
3.2

Introduction
By 2016, at least 42% of all Medicare Fee-For-Service (FFS) acute-care hospital inpatient stays were

discharged to post-acute care (PAC) setting (MedPAC 2017). Between 2001 and 2017, the Medicare annual
expenditure on the long-term and post-acute care (LTPAC) providers has almost doubled to $60 billion
(MedPAC 2017). Despite the increase in discharge and spending, hospital readmission rates from the
LTPAC setting have been as high as 23% coupled with high mortality risk, mostly due to uncoordinated
transition of care or inadequate resources to address patients’ care needs (Burke et al. 2016). Health IT,
defined as information technology used for recording, storing, and exchanging patient health data in a
healthcare setting, is a blanket term including Electronic Health Record (EHR) systems, Decision Support
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Systems (DSS), Computerized Physician Order Entry (CPOE), and more. Health IT has the potential to
improve care coordination for better patient outcomes (Kruse et al. 2015).
Although prior research has investigated the impacts of evolving Health IT systems in acute-care
settings within hospitals and physician offices, there has been very little consideration given to the adoption,
use, and efficacy of Health IT in long-term care settings. Certainly, the role of Health IT in the LTPAC
setting is not merely limited to interoperability between the healthcare providers. It also includes improved
transitional care processes, quality of healthcare service delivery, and reduced costs.
LTPAC facilities differ from acute care hospitals in numerous ways. In contrast to a typical urgentcare or acute-care setting of hospital-based clinical care, LTPAC’s routinized work environment lacks
complexity and urgency. The patient population in LTPAC settings comprises the elderly, typically in
fragile health, and in need of assisted daily living activities. With fee-for-service (FFS) payment models
resulting in acute-care facilities discharging the patients earlier, LTPAC facilities have been essentially
required to adapt by redefining their clinical and operational roles. Consequently, LTPACs have become
more technologically intricate with the latest clinical advancements. These facilities generally provide care
to two different types of patients – patients requiring short-term post-acute care, and those requiring longterm or custodial care due to progressive disease or age (Grabowski 2007). Both acute-care hospitals and
post-acute-care facilities face challenges of reducing hospital readmissions as hospital readmissions act as
a metric for quality of care in most incentive-based federal and state programs. LTPAC facilities serve a
dual role regarding hospital readmissions. On one hand, these facilities provide an alternative to hospital
readmission, while on the other they act as the source of these readmissions.
How do the Health IT adoption and use affect the rapidly evolving long-term and post-acute care
(LTPAC) sector of the U.S. healthcare economy? Health IT holds promises of better care coordination and
improved healthcare outcomes in the LTPAC setting. But still, the rate of Health IT adoption and use by
the LTPAC facilities has been particularly low, almost half of the rate for the acute-care hospitals (Wolf et
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al. 2012). With the use of Health IT, preventable medical errors like adverse drug events can be prevented
through more effective medication reconciliation practices. We intend to extend our understanding of the
effects of Health IT within the LTPAC setting by adopting a configurational perspective towards the
organized complexity of LTPAC facilities. The configurational approach regards these organizations as
clusters of interconnected components that are best viewed systemically to develop a deeper understanding
of complex organizational structure and functions.
Digital technologies are increasingly impacting organizations including healthcare organizations and
thereby transforming the practice of medicine in the digital age (El Sawy et al. 2010). Identifying successful
strategies in the rapidly evolving technological landscape requires a shift in focus from causal elements to
interactions among them (Bharadwaj et al. 2013). Coupling recent research on the role of technology in
healthcare organizations with the theory of complex systems, we argue that information technology
capabilities and other key organizational capabilities are key elements of the business strategy of any
healthcare organization towards better performance. Alternatively, we need to focus on configurations of
capabilities derived from complex systemic interactions (Meyer et al. 1993). Traditional research designs
often fail to adequately address the problems of organized complexity and causality in complex systems
(Meyer et al. 2005).
Meanwhile, identifying systemic patterns emergent from non-linear interactions among multiple
capabilities is not trivial without accommodating these complex non-linear interdependencies within the
research design. In our study, we focus on the configurations of capabilities, rather than treating individual
capabilities as independent variables, in assessing their impact on performance. Additionally, multiple
configurations may lead to the same outcome, the presence of a capability in a high-performance
configuration does not indicate its absence would result in low performance.
The data for our study was obtained from an organization that operates more than 200 long-term and
post-acute care (LTPAC) facilities in multiple states. Our research investigates parsimonious configurations
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for the high qualitative performance of LTPAC facilities with Health IT characterized by systematized
intricacy of organization. Adopting a configurational viewpoint coupled with a fuzzy-set qualitative
comparative analysis (fsQCA) to explain the complex nonlinear relationships among vital technical and
non-technical capabilities in the form of speculative, asymmetric, and equifinal causation. With this
approach, attention shifts from individual capabilities to configurations of capabilities to develop a better
understanding of the complex role of Health IT in the LTPAC sector of healthcare.
3.3

Literature Review
Prior research on the impact of Health IT on health outcomes has been inconclusive (Black et al.

2011). While some researchers provide positive support (Hersh et al., 2014), others find these studies
unconvincing due to limited sample size or weak methodology. Moreover, some critical gaps in the previous
research that examines the impact of Health IT have also been highlighted. With an extensive focus on the
adoption of the technology rather than the value derived from Health IT systems, researchers have faced
issues related to improper measurements (Barnett et al., 2016). Certain other groups of researchers have
been limited in focus covering only a subsection of the patient population and single hospitals, losing
adequate representation and generalizability (Appari et al., 2013). Although the effects of advancing Health
IT have been studied in clinical and physician-office settings, there has been not much investigation done
into the efficacy and viability of Health IT systems in long-term and post-acute care units. There exists a
gap in the current research towards assessing the role of health information systems within the LTPAC
industry as prior research has been focused on the systems design approach or qualitative analysis of the
effect (Clark et al. 2016).
We bridge the critical gap in determining the role of health IT in transitions of care in the LTPAC
industry by adopting the configurational perspective of organizational complexity. LTPAC facilities are
especially complicated as the blanket term of LTPAC includes components like Long-term acute care
hospital (LTACH), Inpatient rehabilitation facility (IRF), Skilled nursing facility (SNF), Home health
agency (HHA), Hospice, Home- and community‑based services (Medicare) (HCBS)/ long-term services
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and supports (Medicaid) (LTSS), and Assisted living facilities (ALF)/continuing care retirement
communities (CCRC). These components differ in the range and intensity of capabilities that include the
complexity of procedures, physician intensity, nursing intensity, therapy services, and support services. As
the patients change starting with one consideration setting then onto the next, an absence of coordination,
correspondence and opportune, substantial clinical data can prompt unfavorable clinical results and
occasions.
3.4

Research Methodology
We perform fuzzy set qualitative comparative analysis as well as econometric event analysis in our

study. The two methods are complementary and help address our research query.
3.4.1

Fuzzy Set Qualitative Comparative Analysis
Facilities data was obtained for operational outcomes described in Table 1. We use a fuzzy set

qualitative comparative analysis (fsQCA) of measured characteristics, and later examine the key features
of fsQCA that relate to our research agenda. The initial phase in the fsQCA includes the calibration
procedure, which distributes the set-participations of each case within high-performance conditions and the
result by changing the estimation of each factor for a case into an enlistment or membership score. For
organizational abilities, we set 50, 40, and 20 EHR as the stays for full membership, crossover, and full
non-participation, correspondingly, for the healthcare facilities. QCA guidelines likewise grant the data
distribution statistics for calibration, e.g., the 75th, 50th, and 25th percentiles for full enrolment, crossover,
and full non-participation, individually.
Once the membership score has been set, the next step involves utilizing a truth table calculation,
which recognizes the configurations of causal conditions (i.e., the six sorts of hierarchical capacities) that
adequately produce the result of intrigue – the truth table for the clinal performance of the LTPAC facilities.
With the consequences of the configuration, each case is assigned into one of a few potential mixes that
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relate to one row in the truth table. This process develops configurations that provide insight into the
complex relationship or these organizational characteristics.
3.4.2

Econometric Event Analysis
Although the event of Health IT adoption was scattered through the observation period, we analyze

the cross-sections obtained at the beginning and end of the observation period with the event having
occurred during the observation period. We exclude facilities that had already implemented Health IT
before January 2016. Then, we create two groups – the control group and the treatment group based on the
facility’s Health IT adoption behavior. The control group consists of facilities that never adopted Health
IT before June 2017. The treatment group consists of those facilities which transition from not using Health
IT to using Health IT during our observation period (January 2016-June 2017). We use difference-indifference methodology to assess treatment effect for the treatment group using the following econometric
model equation:
𝑃𝑒𝑟𝑓𝑜𝑟𝑚𝑎𝑛𝑐𝑒 = 𝛼 + 𝛼 𝐺𝑟𝑜𝑢𝑝 + 𝜆 𝑃𝑜𝑠𝑡𝐸𝑣𝑒𝑛𝑡 + 𝛽 𝐺𝑟𝑜𝑢𝑝 × 𝑃𝑜𝑠𝑡𝐸𝑣𝑒𝑛𝑡
+ 𝛿𝐹𝑎𝑐𝑖𝑙𝑖𝑡𝑦𝐶ℎ𝑎𝑟𝑎𝑐𝑡𝑒𝑟𝑖𝑠𝑡𝑖𝑐𝑠 + 𝜀

(1)

where Performanceit is the clinical, operational, and financial performance of facility i at time t, Groupi
indicates the group facility belongs to - control group or treatment group, and FacilityCharacteristicsit is
control variables for different facility characteristics like the number of beds, consensus, and case-mix.
3.5

Data and Variables
Data were obtained from 168 LTPAC facilities for a period of 18 months. With a total of 18,343

beds across these facilities, the range of skilled nursing facility (SNF) bed count varies between 30 to 240,
with a median of 120 SNF beds. There are twelve measures used by the company to evaluate the
performance of an LTPAC facility, listed along with summary statistics in Table 1.
The level of health IT adoption and use has been recorded for the observation period of 18 months,
starting Jan 2016 to Jun 2017, in the LTPAC facilities within our sample. There are three levels of Health
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IT levels – No EHR usage (level-0), partial EHR or electronic Activities of Daily Living (eADL) use (level1), and Full Clinical EHR system use (level-2). During the observation period, 124 facilities did not change
their Health IT level while 22 switched from level-0 to level-1 and 18 changed to level-2. This switching
provides the required Health IT level variation for investigating its effect on the performance indicators of
these LTPAC facilities.

Table 3.1 Descriptive Statistics of Performance Parameters and Variables
Variables
Operational Performance Indicators
Employee engagement (EE)
Staff retention rate (SRR)
Staff turnover (STO)
Financial Performance Indicators
Staff overtime (OT)
Bad Debt (BD)
Revenue performance against budget (REV)
Clinical Performance Indicators
CMS Five Star Total Score (FST)
CMS Five Star Quality Measure
Complaint Tags Percentage
Facility Deficiency Index (FDI)
Failed Survey Re-Visits
Return to Hospital Percentage (RTH)

3.6

Mean

Standard Deviation

33.37
0.594
0.414

12.37
0.118
0.109

6.304
0.319
439.5

2.886
5.935
21434

2.236
3.461
21.57
1.658
0.0671
16.72

1.238
1.334
25.37
1.082
0.250
4.585

Results and Conclusion
In our data, 58% of the 168 LTPAC facilities had implemented some level of Health IT within the

18 months observation period. Before calibrating variables of the fs-QCA truth-table, we performed
preliminary analysis. The found significant effect of Health IT on the clinical performance indicators, which
needs further investigation from the configurational perspective. Additionally, a similar effect has been
noted in the operational performance indicators.
In general, Health IT with a partial EHR (or eADL) and Full Clinical EHR had wide-ranging effects on
performance in all three categories - Operational, Clinical, and Financial, even though not all indicators
showed an effect. We performed the preliminary analysis of the MANCOVA of the three types of
performance indicators collectively, before the calibration process of fs-QCA, and found a statistically
significant difference in the performance measures of LTPAC facilities based on their Health IT level
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(Hopes, 2017). The one-way MANCOVA presented a statistically significant difference between the
facilities based on their Health IT level on the combined dependent variables, even after controlling for
skilled percent mix. Financial performance indicators present interesting configurational patterns for further
analysis, once we include gross revenue per occupied/licensed bed and bad debt measurements.
Table 3.2 Econometric Event Analysis Model Results
Clinical
Performance
RTH

FDI

TreatmentGro
up

-0.146

-1.473

0.213

0.0148

0.0129

-0.623

-28.39

0.0487

(0.200)
-0.0425
(0.136)
0.0485

(0.943)
0.304
(0.562)
-0.243

(0.242)
-0.0823
(0.0528)
0.163**

(0.0254)
0.00401
(0.0135)
-0.0448*

(0.0216)
-0.0299***
(0.0103)
-0.0381*

(0.560)
-0.220
(0.352)
0.681

(37.08)
-98.63
(71.13)
100.2

(0.125)
-0.264
(0.268)
0.0657

(0.204)
-0.0140*
(0.00767)
0.0100***
(0.00216)
0.877***
(0.300)

(0.865)
0.0226
(0.0384)
0.00526
(0.0117)
16.69***
(1.483)

(0.0776)
0.00186
(0.00612)
-0.00753***
(0.00283)
3.058***
(0.356)

(0.0233)
0.000121
(0.000978)
-0.000169
(0.000316)
0.621***
(0.0393)

(0.0206)
-0.00132
(0.000915)
-0.000322
(0.000268)
0.481***
(0.0342)

(0.583)
-0.0110
(0.0255)
0.0240***
(0.00799)
5.152***
(0.931)

(72.91)
1.938
(2.879)
0.179
(0.347)
-41.78
(88.67)

(0.433)
0.0185
(0.0149)
-0.000164
(0.00307)
-0.286
(0.332)

228
114

228
114

228
114

228
114

228
114

228
114

228
114

228
114

DiD

SkilledPct
BedCount
Constant
Observations
Number of
Facilities

OT

Financial
Performance
REV

VARIABLES

Postevent

FST

Operational
Performance
SRR
STO

BD

Robust standard errors in parentheses
*** p<0.01, ** p<0.05, * p<0.1

We present our econometric model results in Table 3.2. The treatment effect of EHR transition
during the observation period for the facilities in TreatmentGroup is significant for some clinical and
operational performance parameters while it is insignificant for financial performance parameters. The
effect is positive for CMS Five Star Total Score with around 16.3 percentage points increase in this clinical
performance parameter. The effect is negative for Staff Retention Rate with a decline of about 4.5
percentage points and negative for Staff Turnover with a decline of about 3.8 percentage points.
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Table 3.3 fs-QCA Parsimonious Configuration Solutions for High Performance
Configuration
inclS PRI
covS covU
A*B*~C*~E*F*~H*~I*~J
0.785 0.387 0.160 0.009
A*B*~C*~E*~G*~H*~I*~J
0.799 0.425 0.156 0.006
~A*~B*~C*~D*E*F*~H*~I*~J
0.771 0.532 0.185 0.024
~A*~B*~C*~D*E*G*~H*~I*~J
0.764 0.454 0.163 0.005
B*~C*~D*~E*F*~G*~H*~I*~J
0.783 0.437 0.220 0.026
~A*B*~C*D*~E*F*G*H*~I*~J
0.778 0.252 0.124 0.005
~A*~B*~C*D*E*~F*G*~H*~I*J
0.928 0.457 0.069 0.000
M1 -> CMS Five Star Total Score (FST)
0.698 0.412 0.336
1.
~A*~B*~C*~D*~E*H*~I*~J
0.763 0.462 0.233 0.008
2.
A*~C*~D*~E*G*H*~I*~J
0.787 0.358 0.106 0.001
3.
~B*~C*~D*~E*~F*H*~I*~J
0.784 0.434 0.211 0.001
4.
~B*~C*~E*~F*G*H*~I*~J
0.787 0.436 0.210 0.001
5.
~C*~D*~E*F*G*H*~I*~J
0.775 0.429 0.221 0.001
6.
~A*~B*~C*~D*E*~F*G*~H*~I
0.823 0.412 0.076 0.004
7.
~A*~B*~C*~D*E*F*~H*~I*~J
0.815 0.437 0.096 0.003
8.
~A*~B*~C*D*~E*F*~H*~I*~J
0.859 0.512 0.128 0.006
9.
~A*~B*~C*D*~F*G*~H*~I*~J
0.836 0.525 0.138 0.018
10.
~B*~C*~D*E*F*G*~H*~I*~J
0.830 0.461 0.101 0.006
11.
A*B*~C*~D*~E*F*~G*~H*~I*~J
0.822 0.258 0.070 0.014
M2 -> Return to Hospital Percentage (RTH)
0.762 0.513 0.378
12.
~A*~B*~C*~D*E*F*G*~I*~J
0.827 0.441 0.090 0.000
13.
~A*~B*~C*~D*F*G*H*~I*~J
0.772 0.418 0.202 0.000
M3 -> Return to Hospital Percentage (RTH)
0.762 0.514 0.378
1.
~B*~D*~F*~H*~I*~J
0.758 0.652 0.814 0.017
2.
~D*~E*~F*~H*~I*~J
0.774 0.637 0.584 0.011
3.
~A*~B*~C*~D*G*~I*~J
0.748 0.575 0.450 0.003
4.
~A*~B*C*~D*~H*~I*~J
0.810 0.601 0.229 0.010
5.
~A*~D*~F*~G*~H*~I*~J
0.974 0.956 0.460 0.003
6.
A*~C*~D*E*~F*~I*~J
0.881 0.711 0.134 0.001
7.
A*~D*~F*G*~H*~I*~J
0.818 0.506 0.165 0.000
8.
~B*~C*~D*E*~H*~I*~J
0.851 0.752 0.434 0.003
9.
~B*~C*~D*~F*~G*~I*~J
0.947 0.912 0.490 0.004
10.
~C*~D*E*~F*G*~I*~J
0.814 0.635 0.315 0.001
11.
~A*~B*~C*~E*~F*~G*~I*~J
0.981 0.962 0.305 0.005
12.
~A*~B*~C*E*~F*~H*~I*~J
0.853 0.761 0.380 0.003
13.
~A*~B*~C*E*~G*~H*~I*~J
0.978 0.961 0.277 0.001
14.
~A*~B*~D*~E*~F*G*~I*~J
0.773 0.558 0.384 0.002
15.
~A*~B*~D*E*~F*~G*~I*~J
0.975 0.954 0.294 0.001
16.
~A*~B*~C*~D*E*F*~G*~H*~I
0.998 0.990 0.051 0.001
17.
A*~B*~C*E*~F*~G*H*~I*~J
0.984 0.916 0.065 0.000
18.
A*B*~C*E*~F*~G*~H*~I*~J
0.953 0.794 0.048 0.000
M4 -> Staff turnover (STO)
0.741 0.644 0.932
Note: A. Health IT – EHR Capability, B. SkilledPct, C. CMS Five Star Total Score, D. Facility Deficiency Index, E.
Return to Hospital Percentage, F. Employee engagement, G. Staff retention rate, H. Staff turnover, I. Staff overtime,
J. Revenue performance against budget, K. Bad debt.
1.
2.
3.
4.
5.
6.
7.

Given the heterogeneity of some indicators, a qualitative comparative analysis provides for the
exploration of the relationship of Health IT and other predictors on a variety of outcome variables. Some
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nominal and dichotomous variables, like failed revisit surveys, are more suitable to fuzzy set qualitative
analysis (fs-QCA).
Our proposed methodology appropriately identifies the differences among the facilities that have
some influence on the dependent variables of interest allowing for extending inferences beyond the
preliminary indicative analysis. We present parsimonious configuration solutions for high performance
obtained using fs-QCA in Table 3.3. The results indicate no configurations lead to high financial
performance, but some that lead to clinical performance and operational performance. Health IT capability
(EHR) plays an important role that is necessary but not sufficient condition to achieve high performance.
Our results from econometric event analysis and fs-QCA are complementary and suggest Health IT
capability in LTPAC facilities serves as a necessary but not sufficient condition for high performance. This
highlights the role of technology as a catalyst rather than a cause itself in improving performance. In the
future, we plan to include more variables and performance measures to enhance our understanding of the
performance of healthcare organizations in presence of technologies.
3.7
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